{
  "(S)-reticuline biosynthesis II": 1,
  "1,25-dihydroxyvitamin D3 biosynthesis": 3,
  "1D-myo-inositol hexakisphosphate biosynthesis II (mammalian)": 15,
  "1D-myo-inositol hexakisphosphate biosynthesis V (from Ins(1,3,4)P3)": 3,
  "2-LTR circle formation": 7,
  "2-amino-3-carboxymuconate semialdehyde degradation to glutaryl-CoA": 1,
  "2-oxobutanoate degradation I": 7,
  "3' -UTR-mediated translational regulation": 112,
  "3-phosphoinositide biosynthesis": 26,
  "3-phosphoinositide degradation": 20,
  "4-aminobutyrate degradation I": 2,
  "4-hydroxy-2-nonenal detoxification": 5,
  "4-hydroxybenzoate biosynthesis": 1,
  "4-hydroxyphenylpyruvate biosynthesis": 1,
  "4-hydroxyproline degradation I": 1,
  "5-Hydroxytryptamine biosynthesis": 3,
  "5-Hydroxytryptamine degredation": 18,
  "5-aminoimidazole ribonucleotide biosynthesis I": 3,
  "5-arachidonylglycerol_biosynthesis": 7,
  "5HT1 type receptor mediated signaling pathway": 42,
  "5HT2 type receptor mediated signaling pathway": 46,
  "5HT3 type receptor mediated signaling pathway": 13,
  "5HT4 type receptor mediated signaling pathway": 31,
  "A tetrasaccharide linker sequence is required for GAG synthesis": 26,
  "A third proteolytic cleavage releases NICD": 9,
  "ABC transporter disorders": 68,
  "ABC transporters in lipid homeostasis": 18,
  "ABC-family proteins mediated transport": 106,
  "ADP signalling through P2Y purinoceptor 1": 24,
  "ADP signalling through P2Y purinoceptor 12": 22,
  "AKT phosphorylates targets in the cytosol": 13,
  "AKT phosphorylates targets in the nucleus": 8,
  "AKT-mediated inactivation of FOXO1A": 4,
  "ALK1 pathway": 3,
  "ALK1 signaling events": 26,
  "ALK2 signaling events": 11,
  "ALKBH2 mediated reversal of alkylation damage": 1,
  "ALKBH3 mediated reversal of alkylation damage": 4,
  "ALP23B_signaling_pathway": 0,
  "AMER1 mutants destabilize the destruction complex": 14,
  "AMPK inhibits chREBP transcriptional activation activity": 8,
  "AP-1 transcription factor network": 70,
  "APC C-mediated degradation of cell cycle proteins": 86,
  "APC C:Cdc20 mediated degradation of Cyclin B": 23,
  "APC C:Cdc20 mediated degradation of Securin": 67,
  "APC C:Cdc20 mediated degradation of mitotic proteins": 75,
  "APC C:Cdh1 mediated degradation of Cdc20 and other APC C:Cdh1 targeted proteins in late mitosis early G1": 72,
  "APC truncation mutants are not K63 polyubiquitinated": 1,
  "APC truncation mutants have impaired AXIN binding": 14,
  "APC-Cdc20 mediated degradation of Nek2A": 25,
  "APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint": 73,
  "APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway": 7,
  "APOBEC3G mediated resistance to HIV-1 infection": 4,
  "ARL13B-mediated ciliary trafficking of INPP5E": 3,
  "ARMS-mediated activation": 231,
  "ATF-2 transcription factor network": 59,
  "ATF4 activates genes": 25,
  "ATF6 (ATF6-alpha) activates chaperone genes": 9,
  "ATF6 (ATF6-alpha) activates chaperones": 11,
  "ATM pathway": 34,
  "ATP sensitive Potassium channels": 4,
  "ATP synthesis": 2,
  "ATR signaling pathway": 39,
  "AUF1 (hnRNP D0) binds and destabilizes mRNA": 53,
  "AURKA Activation by TPX2": 70,
  "AXIN missense mutants destabilize the destruction complex": 14,
  "AXIN mutants destabilize the destruction complex, activating WNT signaling": 14,
  "Abacavir metabolism": 5,
  "Abacavir transmembrane transport": 5,
  "Abacavir transport and metabolism": 10,
  "Abasic sugar-phosphate removal via the single-nucleotide replacement pathway": 2,
  "Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate": 1,
  "Abortive elongation of HIV-1 transcript in the absence of Tat": 23,
  "Acetate utilization": 3,
  "Acetylation": 2,
  "Acetylcholine Binding And Downstream Events": 14,
  "Acetylcholine Neurotransmitter Release Cycle": 16,
  "Acetylcholine regulates insulin secretion": 10,
  "Acrosome Reaction": 1,
  "Activated NOTCH1 Transmits Signal to the Nucleus": 30,
  "Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3": 67,
  "Activated TLR4 signalling": 112,
  "Activated point mutants of FGFR2": 14,
  "Activation and oligomerization of BAK protein": 2,
  "Activation of AMPA receptors": 4,
  "Activation of APC C and APC C:Cdc20 mediated degradation of mitotic proteins": 76,
  "Activation of ATR in response to replication stress": 37,
  "Activation of BAD and translocation to mitochondria": 15,
  "Activation of BH3-only proteins": 30,
  "Activation of BID and translocation to mitochondria": 4,
  "Activation of BIM and translocation to mitochondria": 3,
  "Activation of BMF and translocation to mitochondria": 3,
  "Activation of C3 and C5": 7,
  "Activation of Ca-permeable Kainate Receptor": 12,
  "Activation of CaMK IV": 4,
  "Activation of DNA fragmentation factor": 13,
  "Activation of G protein gated Potassium channels": 25,
  "Activation of GABAB receptors": 39,
  "Activation of HOX genes during differentiation": 122,
  "Activation of IRF3 IRF7 mediated by TBK1 IKK epsilon": 17,
  "Activation of Kainate Receptors upon glutamate binding": 32,
  "Activation of Matrix Metalloproteinases": 33,
  "Activation of NF-kappaB in B cells": 67,
  "Activation of NIMA Kinases NEK9, NEK6, NEK7": 7,
  "Activation of NMDA receptor upon glutamate binding and postsynaptic events": 41,
  "Activation of NOXA and translocation to mitochondria": 5,
  "Activation of Na-permeable Kainate Receptors": 2,
  "Activation of Nicotinic Acetylcholine Receptors": 14,
  "Activation of PKB": 4,
  "Activation of PPARGC1A (PGC-1alpha) by phosphorylation": 10,
  "Activation of PUMA and translocation to mitochondria": 9,
  "Activation of RAS in B cells": 5,
  "Activation of Rac": 14,
  "Activation of SMO": 18,
  "Activation of TRKA receptors": 6,
  "Activation of anterior HOX genes in hindbrain development during early embryogenesis": 122,
  "Activation of caspases through apoptosome-mediated cleavage": 5,
  "Activation of gene expression by SREBF (SREBP)": 40,
  "Activation of rRNA Expression by ERCC6 (CSB) and EHMT2 (G9a)": 76,
  "Activation of the AP-1 family of transcription factors": 10,
  "Activation of the TFAP2 (AP-2) family of transcription factors": 12,
  "Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S": 60,
  "Activation of the phototransduction cascade": 11,
  "Activation of the pre-replicative complex": 32,
  "Activation, translocation and oligomerization of BAX": 2,
  "Activinbetasignaling_pathway": 0,
  "Acyl chain remodeling of CL": 6,
  "Acyl chain remodeling of DAG and TAG": 7,
  "Acyl chain remodelling of PC": 26,
  "Acyl chain remodelling of PE": 27,
  "Acyl chain remodelling of PG": 18,
  "Acyl chain remodelling of PI": 16,
  "Acyl chain remodelling of PS": 21,
  "Adaptive Immune System": 783,
  "Adenine and hypoxanthine salvage pathway": 6,
  "Adenosine P1 receptors": 4,
  "Adenylate cyclase activating pathway": 10,
  "Adenylate cyclase inhibitory pathway": 14,
  "Adherens junctions interactions": 29,
  "Adrenaline and noradrenaline biosynthesis": 27,
  "Adrenaline signalling through Alpha-2 adrenergic receptor": 2,
  "Adrenaline,noradrenaline inhibits insulin secretion": 28,
  "Adrenoceptors": 8,
  "Advanced glycosylation endproduct receptor signaling": 13,
  "Aflatoxin activation and detoxification": 19,
  "Agmatine biosynthesis": 2,
  "Alanine biosynthesis": 2,
  "Allantoin degradation": 0,
  "Alpha adrenergic receptor signaling pathway": 22,
  "Alpha-defensins": 10,
  "Alpha-oxidation of phytanate": 4,
  "Alpha-synuclein signaling": 30,
  "Alpha4 beta1 integrin signaling events": 33,
  "Alpha6 beta4 integrin-ligand interactions": 11,
  "Alpha9 beta1 integrin signaling events": 25,
  "AlphaE beta7 integrin cell surface interactions": 3,
  "Alternative NF-kappaB pathway": 6,
  "Alternative complement activation": 4,
  "Alzheimer disease-amyloid secretase pathway": 63,
  "Alzheimer disease-presenilin pathway": 110,
  "Amine Oxidase reactions": 3,
  "Amine compound SLC transporters": 30,
  "Amine ligand-binding receptors": 41,
  "Amine-derived hormones": 18,
  "Amino Acid conjugation": 9,
  "Amino acid and derivative metabolism": 348,
  "Amino acid and oligopeptide SLC transporters": 50,
  "Amino acid synthesis and interconversion (transamination)": 27,
  "Amino acid transport across the plasma membrane": 30,
  "Aminobutyrate degradation": 1,
  "Amplification of signal from the kinetochores": 2,
  "Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal": 2,
  "Amyloid fiber formation": 100,
  "Anandamide_degradation": 1,
  "Anchoring fibril formation": 7,
  "Anchoring of the basal body to the plasma membrane": 95,
  "Androgen biosynthesis": 11,
  "Androgen estrogene progesterone biosynthesis": 9,
  "Angiogenesis": 153,
  "Angiopoietin receptor Tie2-mediated signaling": 49,
  "Angiotensin_II-stimulated_signaling_through_G_proteins_and_beta-arrestin": 35,
  "Antagonism of Activin by Follistatin": 4,
  "Antigen Presentation: Folding, assembly and peptide loading of class I MHC": 24,
  "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers": 43,
  "Antigen processing-Cross presentation": 99,
  "Antigen processing: Ubiquitination & Proteasome degradation": 305,
  "Antimicrobial peptides": 95,
  "Antiviral mechanism by IFN-stimulated genes": 69,
  "Apoptosis": 165,
  "Apoptosis induced DNA fragmentation": 13,
  "Apoptosis signaling pathway": 106,
  "Apoptotic cleavage of cell adhesion proteins": 10,
  "Apoptotic cleavage of cellular proteins": 36,
  "Apoptotic execution phase": 50,
  "Apoptotic factor-mediated response": 7,
  "Aquaporin-mediated transport": 52,
  "Arachidonate production from DAG": 5,
  "Arachidonic acid metabolism": 58,
  "Arf1 pathway": 19,
  "Arf6 downstream pathway": 15,
  "Arf6 signaling events": 35,
  "Arf6 trafficking events": 47,
  "Arginine biosynthesis": 6,
  "Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2": 1,
  "Aryl hydrocarbon receptor signalling": 7,
  "Ascorbate degradation": 1,
  "Asparagine N-linked glycosylation": 280,
  "Asparagine and aspartate biosynthesis": 1,
  "Assembly Of The HIV Virion": 13,
  "Assembly of Viral Components at the Budding Site": 2,
  "Assembly of collagen fibrils and other multimeric structures": 56,
  "Assembly of the ORC complex at the origin of replication": 6,
  "Assembly of the pre-replicative complex": 68,
  "Association of TriC CCT with target proteins during biosynthesis": 38,
  "Association of licensing factors with the pre-replicative complex": 15,
  "Astrocytic Glutamate-Glutamine Uptake And Metabolism": 4,
  "Asymmetric localization of PCP proteins": 64,
  "Attachment of GPI anchor to uPAR": 7,
  "Attenuation phase": 12,
  "Atypical NF-kappaB pathway": 14,
  "Aurora A signaling": 31,
  "Aurora B signaling": 38,
  "Aurora C signaling": 3,
  "Autodegradation of Cdh1 by Cdh1:APC C": 63,
  "Autodegradation of the E3 ubiquitin ligase COP1": 52,
  "Autointegration results in viral DNA circles": 3,
  "Axon guidance": 525,
  "Axon guidance mediated by Slit Robo": 18,
  "Axon guidance mediated by netrin": 30,
  "Axon guidance mediated by semaphorins": 19,
  "Axonal growth inhibition (RHOA activation)": 8,
  "Axonal growth stimulation": 4,
  "B Cell Activation": 218,
  "B cell activation": 56,
  "B-WICH complex positively regulates rRNA expression": 90,
  "BARD1 signaling events": 28,
  "BBSome-mediated cargo-targeting to cilium": 23,
  "BCR signaling pathway": 66,
  "BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members": 8,
  "BMAL1:CLOCK,NPAS2 activates circadian gene expression": 45,
  "BMP Signalling Pathway": 5,
  "BMP receptor signaling": 42,
  "BMP_signaling_pathway-drosophila": 0,
  "Base Excision Repair": 36,
  "Base-Excision Repair, AP Site Formation": 9,
  "Basigin interactions": 25,
  "Beta defensins": 41,
  "Beta oxidation of butanoyl-CoA to acetyl-CoA": 5,
  "Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA": 5,
  "Beta oxidation of hexanoyl-CoA to butanoyl-CoA": 5,
  "Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA": 5,
  "Beta oxidation of myristoyl-CoA to lauroyl-CoA": 3,
  "Beta oxidation of octanoyl-CoA to hexanoyl-CoA": 5,
  "Beta oxidation of palmitoyl-CoA to myristoyl-CoA": 3,
  "Beta-catenin independent WNT signaling": 144,
  "Beta-catenin phosphorylation cascade": 17,
  "Beta-oxidation of pristanoyl-CoA": 9,
  "Beta-oxidation of very long chain fatty acids": 5,
  "Beta1 adrenergic receptor signaling pathway": 32,
  "Beta1 integrin cell surface interactions": 66,
  "Beta2 adrenergic receptor signaling pathway": 24,
  "Beta2 integrin cell surface interactions": 29,
  "Beta3 adrenergic receptor signaling pathway": 26,
  "Beta3 integrin cell surface interactions": 42,
  "Beta5 beta6 beta7 and beta8 integrin cell surface interactions": 17,
  "Bicarbonate transporters": 10,
  "Bile acid and bile salt metabolism": 42,
  "Bile salt and organic anion SLC transporters": 14,
  "Binding and Uptake of Ligands by Scavenger Receptors": 49,
  "Binding and entry of HIV virion": 4,
  "Binding of TCF LEF:CTNNB1 to target gene promoters": 7,
  "Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB": 2,
  "Biological oxidations": 214,
  "Biosynthesis of A2E, implicated in retinal degradation": 1,
  "Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein": 78,
  "Biotin biosynthesis": 0,
  "Biotin transport and metabolism": 11,
  "Bloch pathway": 4,
  "Blood coagulation": 38,
  "Branched-chain amino acid catabolism": 23,
  "Breakdown of the nuclear lamina": 2,
  "Budding": 0,
  "Budding and maturation of HIV virion": 25,
  "Bupropion_degradation": 1,
  "Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA": 17,
  "Butyrophilin (BTN) family interactions": 12,
  "C-MYB transcription factor network": 84,
  "C-MYC pathway": 26,
  "C-type lectin receptors (CLRs)": 138,
  "C6 deamination of adenosine": 2,
  "CASP8 activity is inhibited": 10,
  "CD209 (DC-SIGN) signaling": 21,
  "CD22 mediated BCR regulation": 13,
  "CD28 co-stimulation": 31,
  "CD28 dependent PI3K Akt signaling": 22,
  "CD28 dependent Vav1 pathway": 11,
  "CD40 CD40L signaling": 36,
  "CDC42 signaling events": 70,
  "CDC6 association with the ORC:origin complex": 11,
  "CDK-mediated phosphorylation and removal of Cdc6": 51,
  "CDO in myogenesis": 28,
  "CDP-diacylglycerol biosynthesis I": 17,
  "CDT1 association with the CDC6:ORC:origin complex": 59,
  "CHL1 interactions": 9,
  "CLEC7A (Dectin-1) induces NFAT activation": 13,
  "CLEC7A (Dectin-1) signaling": 99,
  "CLEC7A inflammasome pathway": 6,
  "CMP-N-acetylneuraminate biosynthesis I (eukaryotes)": 4,
  "COPI-dependent Golgi-to-ER retrograde traffic": 80,
  "COPI-independent Golgi-to-ER retrograde traffic": 28,
  "COPI-mediated anterograde transport": 77,
  "COPII (Coat Protein 2) Mediated Vesicle Transport": 68,
  "COX reactions": 1,
  "CREB phosphorylation": 7,
  "CREB phosphorylation through the activation of Adenylate Cyclase": 7,
  "CREB phosphorylation through the activation of CaMKII": 17,
  "CREB phosphorylation through the activation of CaMKK": 6,
  "CREB phosphorylation through the activation of Ras": 29,
  "CRMPs in Sema3A signaling": 16,
  "CS DS degradation": 14,
  "CTLA4 inhibitory signaling": 21,
  "CXCR3-mediated signaling events": 38,
  "CXCR4-mediated signaling events": 83,
  "CYP2E1 reactions": 11,
  "Ca activated K+ channels": 9,
  "Ca-dependent events": 30,
  "Ca2+ pathway": 61,
  "CaM pathway": 28,
  "CaMK IV-mediated phosphorylation of CREB": 5,
  "Cadherin signaling pathway": 150,
  "Calcineurin-regulated NFAT-dependent transcription in lymphocytes": 48,
  "Calcitonin-like ligand receptors": 10,
  "Calcium signaling in the CD4+ TCR pathway": 28,
  "Calmodulin induced events": 28,
  "Calnexin calreticulin cycle": 26,
  "Cam-PDE 1 activation": 6,
  "Canonical NF-kappaB pathway": 23,
  "Canonical Wnt signaling pathway": 20,
  "Cap-dependent Translation Initiation": 120,
  "Carbohydrate metabolism": 283,
  "Cardiac conduction": 139,
  "Cargo concentration in the ER": 33,
  "Cargo recognition for clathrin-mediated endocytosis": 97,
  "Cargo trafficking to the periciliary membrane": 52,
  "Carnitine metabolism": 1,
  "Carnitine synthesis": 4,
  "Caspase activation via extrinsic apoptotic signalling pathway": 26,
  "Caspase cascade in apoptosis": 50,
  "Caspase-mediated cleavage of cytoskeletal proteins": 12,
  "Catabolism of glucuronate to xylulose-5-phosphate": 5,
  "Catecholamine biosynthesis": 4,
  "Cation-coupled Chloride cotransporters": 7,
  "Cdc20:Phospho-APC C mediated degradation of Cyclin A": 72,
  "Cell Cycle": 597,
  "Cell Cycle Checkpoints": 200,
  "Cell Cycle, Mitotic": 493,
  "Cell cycle": 14,
  "Cell death signalling via NRAGE, NRIF and NADE": 75,
  "Cell junction organization": 83,
  "Cell redox homeostasis": 0,
  "Cell surface interactions at the vascular wall": 140,
  "Cell-Cell communication": 124,
  "Cell-cell junction organization": 59,
  "Cell-extracellular matrix interactions": 15,
  "Cellular Senescence": 193,
  "Cellular response to heat stress": 83,
  "Cellular response to hypoxia": 75,
  "Cellular responses to stress": 436,
  "Cellular roles of Anthrax toxin": 22,
  "Centrosome maturation": 76,
  "Ceramide signaling pathway": 44,
  "Ceramide signalling": 3,
  "ChREBP activates metabolic gene expression": 7,
  "Chaperonin-mediated protein folding": 95,
  "Chemokine receptors bind chemokines": 48,
  "Chk1 Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex": 12,
  "Cholesterol biosynthesis": 23,
  "Choline catabolism": 6,
  "Chondroitin sulfate biosynthesis": 19,
  "Chondroitin sulfate dermatan sulfate metabolism": 49,
  "Chorismate biosynthesis": 0,
  "Chromatin modifying enzymes": 275,
  "Chromatin organization": 275,
  "Chromosome Maintenance": 109,
  "Chylomicron-mediated lipid transport": 26,
  "Cilium Assembly": 186,
  "Circadian Clock": 67,
  "Circadian clock system": 9,
  "Circadian rhythm pathway": 16,
  "Citric acid cycle (TCA cycle)": 19,
  "Class A 1 (Rhodopsin-like receptors)": 313,
  "Class B 2 (Secretin family receptors)": 90,
  "Class C 3 (Metabotropic glutamate pheromone receptors)": 39,
  "Class I MHC mediated antigen processing & presentation": 366,
  "Class I PI3K signaling events": 43,
  "Class I PI3K signaling events mediated by Akt": 35,
  "Class IB PI3K non-lipid kinase events": 5,
  "Class II GLUTs": 4,
  "Classical Kir channels": 4,
  "Classical antibody-mediated complement activation": 17,
  "Clathrin derived vesicle budding": 72,
  "Clathrin-mediated endocytosis": 135,
  "Clearance of Nuclear Envelope Membranes from Chromatin": 5,
  "Clearance of dopamine": 3,
  "Clearance of seratonin": 3,
  "Cleavage of Growing Transcript in the Termination Region": 65,
  "Cleavage of the damaged purine": 3,
  "Cleavage of the damaged pyrimidine": 7,
  "Clostridium neurotoxicity": 10,
  "Cobalamin (Cbl, vitamin B12) transport and metabolism": 21,
  "Cobalamin biosynthesis": 0,
  "Coenzyme A biosynthesis": 8,
  "Coenzyme A linked carnitine metabolism": 1,
  "Cohesin Loading onto Chromatin": 10,
  "Collagen biosynthesis and modifying enzymes": 67,
  "Collagen chain trimerization": 44,
  "Collagen degradation": 40,
  "Collagen formation": 88,
  "Common Pathway of Fibrin Clot Formation": 22,
  "Complement cascade": 54,
  "Complex I biogenesis": 55,
  "Condensation of Prometaphase Chromosomes": 11,
  "Condensation of Prophase Chromosomes": 73,
  "Conjugation of benzoate with glycine": 6,
  "Conjugation of carboxylic acids": 9,
  "Conjugation of phenylacetate with glutamine": 2,
  "Conjugation of salicylate with glycine": 8,
  "Constitutive Signaling by AKT1 E17K in Cancer": 24,
  "Constitutive Signaling by Aberrant PI3K in Cancer": 52,
  "Constitutive Signaling by EGFRvIII": 14,
  "Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants": 18,
  "Constitutive Signaling by NOTCH1 HD Domain Mutants": 15,
  "Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants": 56,
  "Constitutive Signaling by NOTCH1 PEST Domain Mutants": 56,
  "Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant": 7,
  "Conversion from APC C:Cdc20 to APC C:Cdh1 in late anaphase": 19,
  "Cooperation of PDCL (PhLP1) and TRiC CCT in G-protein beta folding": 42,
  "Cooperation of Prefoldin and TriC CCT in actin and tubulin folding": 33,
  "Coregulation of Androgen receptor activity": 60,
  "Cortocotropin releasing factor receptor signaling pathway": 30,
  "Costimulation by the CD28 family": 65,
  "Creatine metabolism": 11,
  "Creation of C4 and C2 activators": 22,
  "Cross-presentation of particulate exogenous antigens (phagosomes)": 8,
  "Cross-presentation of soluble exogenous antigens (endosomes)": 50,
  "Crosslinking of collagen fibrils": 9,
  "Cyclin A B1 associated events during G2 M transition": 22,
  "Cyclin A:Cdk2-associated events at S phase entry": 70,
  "Cyclin B2 mediated events": 5,
  "Cyclin D associated events in G1": 39,
  "Cyclin E associated events during G1 S transition": 71,
  "Cysteine biosynthesis": 1,
  "Cysteine formation from homocysteine": 2,
  "Cytochrome P450 - arranged by substrate type": 66,
  "Cytochrome c-mediated apoptotic response": 5,
  "Cytokine Signaling in Immune system": 720,
  "Cytoskeletal regulation by Rho GTPase": 70,
  "Cytosolic iron-sulfur cluster assembly": 13,
  "Cytosolic sensors of pathogen-associated DNA": 67,
  "Cytosolic sulfonation of small molecules": 17,
  "Cytosolic tRNA aminoacylation": 24,
  "D-glucuronate degradation I": 2,
  "D-mannose degradation": 1,
  "D-myo-inositol (1,3,4)-trisphosphate biosynthesis": 15,
  "D-myo-inositol (1,4,5)-trisphosphate biosynthesis": 23,
  "D-myo-inositol (1,4,5)-trisphosphate degradation": 13,
  "D-myo-inositol (1,4,5,6)-tetrakisphosphate biosynthesis": 3,
  "D-myo-inositol (3,4,5,6)-tetrakisphosphate biosynthesis": 2,
  "D-myo-inositol-5-phosphate metabolism": 18,
  "DAG and IP3 signaling": 34,
  "DAP12 interactions": 348,
  "DAP12 signaling": 335,
  "DARPP-32 events": 26,
  "DCC mediated attractive signaling": 13,
  "DEx H-box helicases activate type I IFN and inflammatory cytokines production": 13,
  "DNA Damage Bypass": 48,
  "DNA Damage Recognition in GG-NER": 38,
  "DNA Damage Reversal": 8,
  "DNA Damage Telomere Stress Induced Senescence": 80,
  "DNA Double Strand Break Response": 77,
  "DNA Double-Strand Break Repair": 166,
  "DNA Repair": 310,
  "DNA Replication": 108,
  "DNA Replication Pre-Initiation": 85,
  "DNA methylation": 65,
  "DNA replication": 18,
  "DNA replication initiation": 8,
  "DNA strand elongation": 32,
  "DNA-PK pathway in nonhomologous end joining": 13,
  "DPP-SCW_signaling_pathway": 0,
  "DPP_signaling_pathway": 0,
  "DSCAM interactions": 11,
  "De novo purine biosynthesis": 26,
  "De novo pyrimidine deoxyribonucleotide biosynthesis": 12,
  "De novo pyrimidine ribonucleotides biosythesis": 10,
  "Deactivation of the beta-catenin transactivating complex": 42,
  "Deadenylation of mRNA": 23,
  "Deadenylation-dependent mRNA decay": 54,
  "Death Receptor Signalling": 49,
  "Dectin-1 mediated noncanonical NF-kB signaling": 60,
  "Dectin-2 family": 25,
  "Defective ABCA3 causes pulmonary surfactant metabolism dysfunction type 3 (SMDP3)": 5,
  "Defective ABCC8 can cause hypoglycemias and hyperglycemias": 2,
  "Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)": 2,
  "Defective AMN causes hereditary megaloblastic anemia 1": 3,
  "Defective AVP causes neurohypophyseal diabetes insipidus (NDI)": 4,
  "Defective B3GALT6 causes EDSP2 and SEMDJL1": 19,
  "Defective B3GALTL causes Peters-plus syndrome (PpS)": 35,
  "Defective B3GAT3 causes JDSSDHD": 19,
  "Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)": 6,
  "Defective B4GALT7 causes EDS, progeroid type": 19,
  "Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)": 14,
  "Defective CD320 causes methylmalonic aciduria": 2,
  "Defective CFTR causes cystic fibrosis": 61,
  "Defective CHST14 causes EDS, musculocontractural type": 7,
  "Defective CHST3 causes SEDCJD": 7,
  "Defective CHST6 causes MCDC1": 6,
  "Defective CHSY1 causes TPBS": 7,
  "Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)": 8,
  "Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5)": 8,
  "Defective CUBN causes hereditary megaloblastic anemia 1": 3,
  "Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)": 4,
  "Defective EXT1 causes exostoses 1, TRPS2 and CHDS": 12,
  "Defective EXT2 causes exostoses 2": 12,
  "Defective GALNT12 causes colorectal cancer 1 (CRCS1)": 14,
  "Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)": 14,
  "Defective GIF causes intrinsic factor deficiency": 1,
  "Defective HLCS causes multiple carboxylase deficiency": 6,
  "Defective LFNG causes SCDO3": 4,
  "Defective MMAA causes methylmalonic aciduria type cblA": 2,
  "Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC": 1,
  "Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD": 2,
  "Defective MTR causes methylmalonic aciduria and homocystinuria type cblG": 2,
  "Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE": 2,
  "Defective MUT causes methylmalonic aciduria mut type": 2,
  "Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3": 1,
  "Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1": 1,
  "Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2": 1,
  "Defective SFTPA2 causes idiopathic pulmonary fibrosis (IPF)": 2,
  "Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)": 1,
  "Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR)": 1,
  "Defective ST3GAL3 causes MCT12 and EIEE15": 6,
  "Defective TCN2 causes hereditary megaloblastic anemia": 1,
  "Defective TRP may confer susceptibility towards thyroid papillary carcinoma (TPC)": 2,
  "Defective pro-SFTPB causes pulmonary surfactant metabolism dysfunction 1 (SMDP1) and respiratory distress syndrome (RDS)": 3,
  "Defective pro-SFTPC causes pulmonary surfactant metabolism dysfunction 2 (SMDP2) and respiratory distress syndrome (RDS)": 2,
  "Defects in biotin (Btn) metabolism": 6,
  "Defects in cobalamin (B12) metabolism": 11,
  "Defects in vitamin and cofactor metabolism": 17,
  "Defensins": 51,
  "Degradation of AXIN": 55,
  "Degradation of DVL": 57,
  "Degradation of GABA": 2,
  "Degradation of GLI1 by the proteasome": 60,
  "Degradation of GLI2 by the proteasome": 60,
  "Degradation of beta catenin": 18,
  "Degradation of beta-catenin by the destruction complex": 82,
  "Degradation of cysteine and homocysteine": 9,
  "Degradation of the extracellular matrix": 108,
  "Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium Channels": 12,
  "Depolymerisation of the Nuclear Lamina": 13,
  "Deposition of new CENPA-containing nucleosomes at the centromere": 73,
  "Depurination": 3,
  "Depyrimidination": 7,
  "Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models": 21,
  "Dermatan sulfate biosynthesis": 11,
  "Detoxification of Reactive Oxygen Species": 34,
  "Deubiquitination": 296,
  "Developmental Biology": 1039,
  "Digestion of dietary carbohydrate": 9,
  "Digestion of dietary lipid": 15,
  "Dimerization of procaspase-8": 10,
  "Direct p53 effectors": 141,
  "Disassembly of the destruction complex and recruitment of AXIN to the membrane": 31,
  "Disease": 812,
  "Diseases associated with O-glycosylation of proteins": 54,
  "Diseases associated with glycosaminoglycan metabolism": 25,
  "Diseases associated with surfactant metabolism": 10,
  "Diseases associated with the TLR signaling cascade": 24,
  "Diseases associated with visual transduction": 10,
  "Diseases of Immune System": 24,
  "Diseases of carbohydrate metabolism": 10,
  "Diseases of glycosylation": 79,
  "Diseases of metabolism": 44,
  "Diseases of signal transduction": 347,
  "Disinhibition of SNARE formation": 5,
  "Disorders of transmembrane transporters": 75,
  "Displacement of DNA glycosylase by APEX1": 8,
  "Dissolution of Fibrin Clot": 13,
  "Dopamine Neurotransmitter Release Cycle": 21,
  "Dopamine receptors": 5,
  "Downregulation of ERBB2 signaling": 27,
  "Downregulation of ERBB2:ERBB3 signaling": 12,
  "Downregulation of ERBB4 signaling": 7,
  "Downregulation of SMAD2 3:SMAD4 transcriptional activity": 23,
  "Downregulation of TGF-beta receptor signaling": 25,
  "Downstream TCR signaling": 96,
  "Downstream signal transduction": 332,
  "Downstream signaling events of B Cell Receptor (BCR)": 181,
  "Downstream signaling in naive CD8+ T cells": 66,
  "Downstream signaling of activated FGFR1": 24,
  "Downstream signaling of activated FGFR2": 24,
  "Downstream signaling of activated FGFR3": 19,
  "Downstream signaling of activated FGFR4": 23,
  "Dual Incision in GG-NER": 41,
  "Dual incision in TC-NER": 65,
  "E-cadherin signaling events": 3,
  "E-cadherin signaling in keratinocytes": 21,
  "E-cadherin signaling in the nascent adherens junction": 36,
  "E2F mediated regulation of DNA replication": 34,
  "E2F transcription factor network": 73,
  "E2F-enabled inhibition of pre-replication complex formation": 10,
  "E3 ubiquitin ligases ubiquitinate target proteins": 42,
  "ECM proteoglycans": 54,
  "EGF receptor (ErbB1) signaling pathway": 32,
  "EGF receptor signaling pathway": 115,
  "EGFR Transactivation by Gastrin": 8,
  "EGFR downregulation": 24,
  "EGFR interacts with phospholipase C-gamma": 36,
  "EGFR-dependent Endothelin signaling events": 9,
  "EPH-Ephrin signaling": 92,
  "EPH-ephrin mediated repulsion of cells": 46,
  "EPHA forward signaling": 33,
  "EPHA-mediated growth cone collapse": 32,
  "EPHA2 forward signaling": 19,
  "EPHB forward signaling": 39,
  "EPHB-mediated forward signaling": 40,
  "EPO signaling pathway": 32,
  "ER Quality Control Compartment (ERQC)": 21,
  "ER to Golgi Anterograde Transport": 130,
  "ER-Phagosome pathway": 83,
  "ERBB2 Activates PTK6 Signaling": 11,
  "ERBB2 Regulates Cell Motility": 13,
  "ERK MAPK targets": 22,
  "ERKs are inactivated": 13,
  "Early Phase of HIV Life Cycle": 14,
  "Effects of Botulinum toxin": 9,
  "Effects of PIP2 hydrolysis": 27,
  "Eicosanoid ligand-binding receptors": 15,
  "Eicosanoids": 12,
  "Elastic fibre formation": 41,
  "Electric Transmission Across Gap Junctions": 5,
  "Electron transport from NADPH to Ferredoxin": 3,
  "Elevation of cytosolic Ca2+ levels": 16,
  "Elongation arrest and recovery": 49,
  "Endogenous TLR signaling": 24,
  "Endogenous sterols": 27,
  "Endogenous_cannabinoid_signaling": 23,
  "Endosomal Sorting Complex Required For Transport (ESCRT)": 28,
  "Endosomal Vacuolar pathway": 11,
  "Endothelins": 63,
  "Energy dependent regulation of mTOR by LKB1-AMPK": 28,
  "Enkephalin release": 33,
  "Entry of Influenza Virion into Host Cell via Endocytosis": 2,
  "Enzymatic degradation of Dopamine by monoamine oxidase": 2,
  "Enzymatic degradation of dopamine by COMT": 2,
  "Ephrin A reverse signaling": 3,
  "Ephrin B reverse signaling": 26,
  "Ephrin signaling": 17,
  "EphrinA-EPHA pathway": 8,
  "EphrinB-EPHB pathway": 6,
  "Epigenetic regulation of gene expression": 147,
  "ErbB receptor signaling network": 15,
  "ErbB1 downstream signaling": 104,
  "ErbB2 ErbB3 signaling events": 41,
  "ErbB4 signaling events": 35,
  "Erythrocytes take up carbon dioxide and release oxygen": 13,
  "Erythrocytes take up oxygen and release carbon dioxide": 9,
  "Establishment of Sister Chromatid Cohesion": 11,
  "Estrogen biosynthesis": 6,
  "Ethanol oxidation": 12,
  "Eukaryotic Translation Elongation": 94,
  "Eukaryotic Translation Initiation": 120,
  "Eukaryotic Translation Termination": 94,
  "Export of Viral Ribonucleoproteins from Nucleus": 27,
  "Extension of Telomeres": 30,
  "Extracellular matrix organization": 286,
  "Extrinsic Pathway of Fibrin Clot Formation": 5,
  "FAS (CD95) signaling pathway": 35,
  "FAS signaling pathway": 30,
  "FBXL7 down-regulates AURKA during mitotic entry and in early mitosis": 55,
  "FBXW7 Mutants and NOTCH1 in Cancer": 4,
  "FCERI mediated Ca+2 mobilization": 36,
  "FCERI mediated MAPK activation": 256,
  "FCERI mediated NF-kB activation": 87,
  "FCGR activation": 21,
  "FGF signaling pathway": 104,
  "FGFR1 ligand binding and activation": 11,
  "FGFR1 mutant receptor activation": 26,
  "FGFR1b ligand binding and activation": 5,
  "FGFR1c and Klotho ligand binding and activation": 1,
  "FGFR1c ligand binding and activation": 8,
  "FGFR2 alternative splicing": 26,
  "FGFR2 ligand binding and activation": 16,
  "FGFR2 mutant receptor activation": 30,
  "FGFR2b ligand binding and activation": 9,
  "FGFR2c ligand binding and activation": 9,
  "FGFR3 ligand binding and activation": 9,
  "FGFR3 mutant receptor activation": 9,
  "FGFR3b ligand binding and activation": 4,
  "FGFR3c ligand binding and activation": 9,
  "FGFR4 ligand binding and activation": 12,
  "FGFR4 mutant receptor activation": 1,
  "FGFRL1 modulation of FGFR1 signaling": 10,
  "FMO oxidises nucleophiles": 3,
  "FOXA transcription factor networks": 3,
  "FOXA1 transcription factor network": 44,
  "FOXA2 and FOXA3 transcription factor networks": 44,
  "FOXM1 transcription factor network": 42,
  "FRS-mediated FGFR1 signaling": 17,
  "FRS-mediated FGFR2 signaling": 20,
  "FRS-mediated FGFR3 signaling": 15,
  "FRS-mediated FGFR4 signaling": 19,
  "Facilitative Na+-independent glucose transporters": 14,
  "Factors involved in megakaryocyte development and platelet production": 150,
  "Fanconi Anemia Pathway": 39,
  "Fanconi anemia pathway": 47,
  "FasL  CD95L signaling": 5,
  "Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion": 8,
  "Fatty Acyl-CoA Biosynthesis": 51,
  "Fatty acid, triacylglycerol, and ketone body metabolism": 238,
  "Fatty acids": 15,
  "Fc epsilon receptor (FCERI) signaling": 361,
  "Fc-epsilon receptor I signaling in mast cells": 60,
  "Fcgamma receptor (FCGR) dependent phagocytosis": 93,
  "Fertilization": 26,
  "Fibronectin matrix formation": 6,
  "Ficolins bind to repetitive carbohydrate structures on the target cell surface": 4,
  "Flavin biosynthesis": 2,
  "Folding of actin by CCT TriC": 10,
  "Formation of ATP by chemiosmotic coupling": 18,
  "Formation of Fibrin Clot (Clotting Cascade)": 39,
  "Formation of HIV elongation complex in the absence of HIV Tat": 48,
  "Formation of HIV-1 elongation complex containing HIV-1 Tat": 46,
  "Formation of Incision Complex in GG-NER": 43,
  "Formation of RNA Pol II elongation complex": 61,
  "Formation of Senescence-Associated Heterochromatin Foci (SAHF)": 16,
  "Formation of TC-NER Pre-Incision Complex": 53,
  "Formation of a pool of free 40S subunits": 102,
  "Formation of annular gap junctions": 9,
  "Formation of apoptosome": 3,
  "Formation of editosomes by ADAR proteins": 2,
  "Formation of the Early Elongation Complex": 33,
  "Formation of the Editosome": 8,
  "Formation of the HIV-1 Early Elongation Complex": 33,
  "Formation of the active cofactor, UDP-glucuronate": 3,
  "Formation of the beta-catenin:TCF transactivating complex": 90,
  "Formation of the cornified envelope": 71,
  "Formation of the ternary complex, and subsequently, the 43S complex": 52,
  "Formation of tubulin folding intermediates by CCT TriC": 26,
  "Formyl peptide receptors bind formyl peptides and many other ligands": 7,
  "Formyltetrahydroformate biosynthesis": 6,
  "FoxO family signaling": 48,
  "Free fatty acid receptors": 5,
  "Free fatty acids regulate insulin secretion": 8,
  "Frs2-mediated activation": 232,
  "Fructose biosynthesis": 2,
  "Fructose catabolism": 5,
  "Fructose galactose metabolism": 9,
  "Fructose metabolism": 7,
  "Fusion and Uncoating of the Influenza Virion": 0,
  "Fusion of the Influenza Virion to the Host Cell Endosome": 0,
  "G alpha (12 13) signalling events": 87,
  "G alpha (i) signalling events": 240,
  "G alpha (q) signalling events": 189,
  "G alpha (s) signalling events": 143,
  "G alpha (z) signalling events": 46,
  "G beta:gamma signalling through PI3Kgamma": 47,
  "G beta:gamma signalling through PLC beta": 20,
  "G protein gated Potassium channels": 25,
  "G-protein activation": 28,
  "G-protein beta:gamma signalling": 50,
  "G-protein mediated events": 47,
  "G0 and Early G1": 25,
  "G1 Phase": 39,
  "G1 S DNA Damage Checkpoints": 66,
  "G1 S Transition": 118,
  "G1 S-Specific Transcription": 18,
  "G2 M Checkpoints": 168,
  "G2 M DNA damage checkpoint": 95,
  "G2 M DNA replication checkpoint": 5,
  "G2 M Transition": 173,
  "G2 Phase": 5,
  "GAB1 signalosome": 113,
  "GABA A (rho) receptor activation": 3,
  "GABA A receptor activation": 13,
  "GABA B receptor activation": 39,
  "GABA receptor activation": 55,
  "GABA synthesis": 2,
  "GABA synthesis, release, reuptake and degradation": 18,
  "GABA-B_receptor_II_signaling": 35,
  "GBB_signaling_pathway": 0,
  "GDP-L-fucose biosynthesis I (from GDP-D-mannose)": 2,
  "GDP-L-fucose biosynthesis II (from L-fucose)": 2,
  "GDP-fucose biosynthesis": 6,
  "GDP-glucose biosynthesis": 5,
  "GDP-mannose biosynthesis": 6,
  "GLI proteins bind promoters of Hh responsive genes to promote transcription": 3,
  "GLI3 is processed to GLI3R by the proteasome": 60,
  "GMCSF-mediated signaling events": 36,
  "GP1b-IX-V activation signalling": 9,
  "GPCR downstream signaling": 971,
  "GPCR ligand binding": 442,
  "GPVI-mediated activation cascade": 53,
  "GRB2 events in EGFR signaling": 227,
  "GRB2 events in ERBB2 signaling": 14,
  "GRB2:SOS provides linkage to MAPK signaling for Integrins": 13,
  "GRB7 events in ERBB2 signaling": 4,
  "GSD 0": 2,
  "GSD 0 (muscle)": 2,
  "GSD II": 2,
  "GSD IV": 4,
  "GSD XV": 2,
  "GTP hydrolysis and joining of the 60S ribosomal subunit": 113,
  "Galactose catabolism": 5,
  "Gamma carboxylation, hypusine formation and arylsulfatase activation": 38,
  "Gamma-aminobutyric acid synthesis": 5,
  "Gamma-carboxylation of protein precursors": 10,
  "Gamma-carboxylation, transport, and amino-terminal cleavage of proteins": 11,
  "Gap junction assembly": 19,
  "Gap junction degradation": 10,
  "Gap junction trafficking": 28,
  "Gap junction trafficking and regulation": 29,
  "Gap-filling DNA repair synthesis and ligation in GG-NER": 25,
  "Gap-filling DNA repair synthesis and ligation in TC-NER": 64,
  "Gastrin-CREB signalling pathway via PKC and MAPK": 422,
  "Gastrin_CCK2R_240212": 149,
  "Gene Expression": 1744,
  "Gene Silencing by RNA": 131,
  "General transcription by RNA polymerase I": 15,
  "General transcription regulation": 31,
  "Generation of second messenger molecules": 32,
  "Generic Transcription Pathway": 830,
  "Global Genome Nucleotide Excision Repair (GG-NER)": 84,
  "Glucagon signaling in metabolic regulation": 33,
  "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion": 42,
  "Glucagon-type ligand receptors": 30,
  "Glucocorticoid biosynthesis": 9,
  "Glucocorticoid receptor regulatory network": 82,
  "Gluconeogenesis": 32,
  "Glucose metabolism": 79,
  "Glucose transport": 41,
  "Glucuronidation": 24,
  "Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity": 26,
  "Glutamate Neurotransmitter Release Cycle": 23,
  "Glutamine glutamate conversion": 4,
  "Glutathione conjugation": 36,
  "Glutathione synthesis and recycling": 12,
  "Glycerophospholipid biosynthesis": 124,
  "Glycerophospholipid catabolism": 7,
  "Glycine degradation": 4,
  "Glycogen breakdown (glycogenolysis)": 17,
  "Glycogen storage diseases": 10,
  "Glycogen synthesis": 15,
  "Glycolysis": 30,
  "Glycoprotein hormones": 9,
  "Glycosaminoglycan metabolism": 120,
  "Glycosphingolipid metabolism": 44,
  "Glyoxylate metabolism and glycine degradation": 25,
  "Glypican 1 network": 26,
  "Glypican 2 network": 2,
  "Glypican 3 network": 8,
  "Glypican pathway": 3,
  "Golgi Associated Vesicle Biogenesis": 54,
  "Golgi Cisternae Pericentriolar Stack Reorganization": 13,
  "Golgi-to-ER retrograde transport": 108,
  "Growth hormone receptor signaling": 22,
  "HATs acetylate histones": 143,
  "HCN channels": 4,
  "HDACs deacetylate histones": 93,
  "HDL-mediated lipid transport": 17,
  "HDMs demethylate histones": 51,
  "HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)": 132,
  "HDR through Homologous Recombination (HRR)": 67,
  "HDR through MMEJ (alt-NHEJ)": 10,
  "HDR through Single Strand Annealing (SSA)": 37,
  "HHAT G278V abrogates palmitoylation of Hh-Np": 3,
  "HIF-1-alpha transcription factor network": 65,
  "HIF-2-alpha transcription factor network": 34,
  "HIV Infection": 224,
  "HIV Life Cycle": 144,
  "HIV Transcription Elongation": 46,
  "HIV Transcription Initiation": 47,
  "HIV elongation arrest and recovery": 36,
  "HIV-1 Nef: Negative effector of Fas and TNF-alpha": 33,
  "HS-GAG biosynthesis": 31,
  "HS-GAG degradation": 21,
  "HSF1 activation": 12,
  "HSF1-dependent transactivation": 22,
  "Hedgehog 'off' state": 100,
  "Hedgehog 'on' state": 85,
  "Hedgehog ligand biogenesis": 65,
  "Hedgehog signaling events mediated by Gli proteins": 48,
  "Hedgehog signaling pathway": 19,
  "Heme biosynthesis": 11,
  "Heme degradation": 6,
  "Hemostasis": 622,
  "Heparan sulfate heparin (HS-GAG) metabolism": 54,
  "Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway": 151,
  "Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway": 118,
  "Heterotrimeric G-protein signaling pathway-rod outer segment phototransduction": 35,
  "Hexose uptake": 49,
  "Hh mutants abrogate ligand secretion": 58,
  "Hh mutants that don't undergo autocatalytic processing are degraded by ERAD": 56,
  "Highly calcium permeable nicotinic acetylcholine receptors": 9,
  "Highly calcium permeable postsynaptic nicotinic acetylcholine receptors": 11,
  "Highly sodium permeable acetylcholine nicotinic receptors": 7,
  "Histamine H1 receptor mediated signaling pathway": 41,
  "Histamine H2 receptor mediated signaling pathway": 24,
  "Histamine receptors": 4,
  "Histamine synthesis": 1,
  "Histidine biosynthesis": 0,
  "Histidine catabolism": 8,
  "Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism": 44,
  "Homologous DNA Pairing and Strand Exchange": 42,
  "Homology Directed Repair": 138,
  "Hormone ligand-binding receptors": 12,
  "Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis": 20,
  "Host Interactions of HIV factors": 124,
  "Host Interactions with Influenza Factors": 38,
  "HuR (ELAVL1) binds and stabilizes mRNA": 8,
  "Huntington disease": 116,
  "Hyaluronan biosynthesis and export": 5,
  "Hyaluronan metabolism": 17,
  "Hyaluronan uptake and degradation": 12,
  "Hydrolysis of LPC": 7,
  "Hydrolysis of LPE": 2,
  "Hydroxycarboxylic acid-binding receptors": 3,
  "Hypoxia response via HIF activation": 16,
  "Hypoxic and oxygen homeostasis regulation of HIF-1-alpha": 19,
  "Hypusinylation": 4,
  "IFN-gamma pathway": 43,
  "IGF1 pathway": 29,
  "IGF1R signaling cascade": 280,
  "IKBKB deficiency causes SCID": 2,
  "IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)": 8,
  "IKK complex recruitment mediated by RIP1": 23,
  "IL-6-type cytokine receptor ligand interactions": 20,
  "IL1-mediated signaling events": 34,
  "IL12 signaling mediated by STAT4": 30,
  "IL12-mediated signaling events": 60,
  "IL2 signaling events mediated by PI3K": 36,
  "IL2 signaling events mediated by STAT5": 30,
  "IL2-mediated signaling events": 54,
  "IL23-mediated signaling events": 37,
  "IL27-mediated signaling events": 26,
  "IL3-mediated signaling events": 26,
  "IL4-mediated signaling events": 62,
  "IL5-mediated signaling events": 14,
  "IL6-mediated signaling events": 47,
  "IL8- and CXCR1-mediated signaling events": 28,
  "IL8- and CXCR2-mediated signaling events": 34,
  "IL8-mediated signaling events": 1,
  "IRAK1 recruits IKK complex": 10,
  "IRAK1 recruits IKK complex upon TLR7 8 or 9 stimulation": 10,
  "IRAK2 mediated activation of TAK1 complex": 10,
  "IRAK2 mediated activation of TAK1 complex upon TLR7 8 or 9 stimulation": 16,
  "IRAK4 deficiency (TLR2 4)": 11,
  "IRAK4 deficiency (TLR5)": 4,
  "IRE1alpha activates chaperones": 54,
  "IRF3 mediated activation of type 1 IFN": 5,
  "IRF3-mediated induction of type I IFN": 13,
  "IRS activation": 5,
  "IRS-mediated signalling": 276,
  "IRS-related events triggered by IGF1R": 280,
  "ISG15 antiviral mechanism": 69,
  "IkBA variant leads to EDA-ID": 7,
  "Immune System": 2038,
  "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell": 122,
  "Import of palmitoyl-CoA into the mitochondrial matrix": 11,
  "Inactivation of APC C via direct inhibition of the APC C complex": 20,
  "Inactivation of Cdc42 and Rac": 8,
  "Inactivation, recovery and regulation of the phototransduction cascade": 32,
  "Incretin synthesis, secretion, and inactivation": 22,
  "Infectious disease": 368,
  "Inflammasomes": 20,
  "Inflammation mediated by chemokine and cytokine signaling pathway": 198,
  "Influenza Infection": 150,
  "Influenza Life Cycle": 139,
  "Influenza Viral RNA Transcription and Replication": 131,
  "Influenza Virus Induced Apoptosis": 2,
  "Inhibition of HSL": 2,
  "Inhibition of Host mRNA Processing and RNA Silencing": 2,
  "Inhibition of IFN-beta": 0,
  "Inhibition of Interferon Synthesis": 0,
  "Inhibition of PKR": 1,
  "Inhibition of Signaling by Overexpressed EGFR": 2,
  "Inhibition of TSC complex formation by PKB": 3,
  "Inhibition of adenylate cyclase pathway": 14,
  "Inhibition of replication initiation of damaged DNA by RB1 E2F1": 13,
  "Inhibition of the proteolytic activity of APC C required for the onset of anaphase by mitotic spindle checkpoint components": 20,
  "Inhibition of voltage gated Ca2+ channels via Gbeta gamma subunits": 25,
  "Initial triggering of complement": 32,
  "Initiation of Nuclear Envelope Reformation": 10,
  "InlA-mediated entry of Listeria monocytogenes into host cells": 9,
  "InlB-mediated entry of Listeria monocytogenes into host cell": 14,
  "Innate Immune System": 1247,
  "Inositol phosphate metabolism": 47,
  "Inositol transporters": 7,
  "Insulin IGF pathway-mitogen activated protein kinase kinase MAP kinase cascade": 29,
  "Insulin IGF pathway-protein kinase B signaling cascade": 23,
  "Insulin Pathway": 43,
  "Insulin effects increased synthesis of Xylulose-5-Phosphate": 2,
  "Insulin processing": 28,
  "Insulin receptor recycling": 26,
  "Insulin receptor signalling cascade": 279,
  "Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs IMPs VICKZs) bind RNA": 3,
  "Insulin-mediated glucose transport": 29,
  "Integration of energy metabolism": 109,
  "Integration of provirus": 9,
  "Integration of viral DNA into host genomic DNA": 3,
  "Integrin alphaIIb beta3 signaling": 25,
  "Integrin cell surface interactions": 65,
  "Integrin family cell surface interactions": 26,
  "Integrin signalling pathway": 163,
  "Integrin-linked kinase signaling": 44,
  "Integrins in angiogenesis": 61,
  "Interaction With Cumulus Cells": 1,
  "Interaction With The Zona Pellucida": 10,
  "Interaction between L1 and Ankyrins": 29,
  "Interaction between PHLDA1 and AURKA": 2,
  "Interactions of Rev with host cellular proteins": 32,
  "Interactions of Tat with host cellular proteins": 2,
  "Interactions of Vpr with host cellular proteins": 32,
  "Interactions of neurexins and neuroligins at synapses": 56,
  "Interconversion of 2-oxoglutarate and 2-hydroxyglutarate": 3,
  "Interconversion of polyamines": 2,
  "Interferon Signaling": 190,
  "Interferon alpha beta signaling": 65,
  "Interferon gamma signaling": 90,
  "Interferon-gamma signaling pathway": 28,
  "Interleukin receptor SHC signaling": 237,
  "Interleukin signaling pathway": 88,
  "Interleukin-1 processing": 7,
  "Interleukin-1 signaling": 43,
  "Interleukin-10 signaling": 48,
  "Interleukin-12 signaling": 4,
  "Interleukin-17 signaling": 8,
  "Interleukin-19, 20, 22, 24": 9,
  "Interleukin-2 signaling": 244,
  "Interleukin-3, 5 and GM-CSF signaling": 253,
  "Interleukin-4 and 13 signaling": 111,
  "Interleukin-6 family signaling": 26,
  "Interleukin-6 signaling": 10,
  "Interleukin-7 signaling": 28,
  "Internalization of ErbB1": 38,
  "Intestinal infectious diseases": 2,
  "Intra-Golgi and retrograde Golgi-to-ER traffic": 177,
  "Intra-Golgi traffic": 44,
  "Intraflagellar transport": 41,
  "Intrinsic Pathway for Apoptosis": 43,
  "Intrinsic Pathway of Fibrin Clot Formation": 22,
  "Inwardly rectifying K+ channels": 31,
  "Ion channel transport": 205,
  "Ion homeostasis": 54,
  "Ion influx efflux at host-pathogen interface": 4,
  "Ion transport by P-type ATPases": 57,
  "Ionotropic activity of Kainate Receptors": 12,
  "Ionotropic glutamate receptor pathway": 41,
  "Iron uptake and transport": 43,
  "Isoleucine biosynthesis": 3,
  "JAK STAT signaling pathway": 15,
  "JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1": 18,
  "JNK signaling in the CD4+ TCR pathway": 14,
  "Josephin domain DUBs": 12,
  "KSRP (KHSRP) binds and destabilizes mRNA": 17,
  "Kandutsch-Russell pathway": 4,
  "Keratan sulfate biosynthesis": 27,
  "Keratan sulfate degradation": 11,
  "Keratan sulfate keratin metabolism": 32,
  "Keratinization": 213,
  "Ketone body catabolism": 3,
  "Ketone body metabolism": 9,
  "Kinesins": 41,
  "L-carnitine biosynthesis": 3,
  "L-cysteine degradation I": 2,
  "L-cysteine degradation II": 1,
  "L-cysteine degradation III": 1,
  "L-dopa degradation": 1,
  "L-dopachrome biosynthesis": 1,
  "L-glutamine biosynthesis II (tRNA-dependent)": 2,
  "L-serine degradation": 2,
  "L13a-mediated translational silencing of Ceruloplasmin expression": 112,
  "L1CAM interactions": 97,
  "LDL endocytosis": 22,
  "LGI-ADAM interactions": 14,
  "LKB1 signaling events": 42,
  "LPA receptor mediated events": 64,
  "LPA4-mediated signaling events": 15,
  "LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production": 5,
  "Lactose synthesis": 3,
  "Lagging Strand Synthesis": 20,
  "Laminin interactions": 23,
  "Late Phase of HIV Life Cycle": 131,
  "Latent infection of Homo sapiens with Mycobacterium tuberculosis": 1,
  "Leading Strand Synthesis": 14,
  "Lectin pathway of complement activation": 5,
  "Leucine biosynthesis": 2,
  "Leukotriene receptors": 5,
  "Ligand-dependent caspase activation": 16,
  "Ligand-gated ion channel transport": 26,
  "Ligand-independent caspase activation via DCC": 10,
  "Ligand-receptor interactions": 8,
  "Linoleic acid (LA) metabolism": 8,
  "Lipid and lipoprotein metabolism": 107,
  "Lipoate_biosynthesis": 1,
  "Lipoprotein metabolism": 68,
  "Lissencephaly gene (LIS1) in neuronal migration and development": 31,
  "Listeria monocytogenes entry into host cells": 19,
  "Localization of the PINCH-ILK-PARVIN complex to focal adhesions": 3,
  "Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling": 4,
  "Loss of Function of SMAD2 3 in Cancer": 6,
  "Loss of Function of SMAD4 in Cancer": 3,
  "Loss of Function of TGFBR1 in Cancer": 6,
  "Loss of Function of TGFBR2 in Cancer": 4,
  "Loss of Nlp from mitotic centrosomes": 67,
  "Loss of proteins required for interphase microtubule organization from the centrosome": 67,
  "Lysine biosynthesis": 0,
  "Lysine catabolism": 12,
  "Lysosomal glycogen catabolism": 3,
  "Lysosomal oligosaccharide catabolism": 4,
  "Lysosome Vesicle Biogenesis": 35,
  "Lysosphingolipid and LPA receptors": 9,
  "M G1 Transition": 85,
  "M Phase": 294,
  "MAP kinase activation in TLR cascade": 63,
  "MAP kinase cascade": 1,
  "MAP2K and MAPK activation": 37,
  "MAP3K8 (TPL2)-dependent MAPK1 3 activation": 16,
  "MAPK family signaling cascades": 271,
  "MAPK targets  Nuclear events mediated by MAP kinases": 31,
  "MAPK1 (ERK2) activation": 8,
  "MAPK1 MAPK3 signaling": 232,
  "MAPK3 (ERK1) activation": 9,
  "MAPK6 MAPK4 signaling": 89,
  "MASTL Facilitates Mitotic Progression": 10,
  "MET Receptor Activation": 6,
  "MET activates PI3K AKT signaling": 5,
  "MET activates PTK2 signaling": 18,
  "MET activates PTPN11": 4,
  "MET activates RAP1 and RAC1": 10,
  "MET activates RAS signaling": 9,
  "MET activates STAT3": 3,
  "MET interacts with TNS proteins": 5,
  "MET promotes cell motility": 28,
  "MET receptor recycling": 9,
  "MGMT-mediated DNA damage reversal": 1,
  "MHC class II antigen presentation": 102,
  "MMR": 15,
  "MYO_signaling_pathway": 0,
  "Macroautophagy": 66,
  "Major pathway of rRNA processing in the nucleolus and cytosol": 172,
  "Mannose metabolism": 6,
  "Meiosis": 117,
  "Meiotic recombination": 87,
  "Meiotic synapsis": 77,
  "Melanin biosynthesis": 5,
  "Membrane Trafficking": 600,
  "Membrane binding and targetting of GAG proteins": 11,
  "Metabolic disorders of biological oxidation enzymes": 6,
  "Metabolism": 2090,
  "Metabolism of Angiotensinogen to Angiotensins": 17,
  "Metabolism of fat-soluble vitamins": 52,
  "Metabolism of folate and pterines": 16,
  "Metabolism of ingested H2SeO4 and H2SeO3 into H2Se": 3,
  "Metabolism of ingested MeSeO2H into MeSeH": 1,
  "Metabolism of ingested SeMet, Sec, MeSec into H2Se": 8,
  "Metabolism of lipids and lipoproteins": 776,
  "Metabolism of nitric oxide": 22,
  "Metabolism of polyamines": 85,
  "Metabolism of proteins": 1568,
  "Metabolism of serotonin": 2,
  "Metabolism of steroid hormones": 32,
  "Metabolism of vitamin K": 3,
  "Metabolism of vitamins and cofactors": 169,
  "Metabolism of water-soluble vitamins and cofactors": 118,
  "Metabotropic glutamate receptor group I pathway": 24,
  "Metabotropic glutamate receptor group II pathway": 42,
  "Metabotropic glutamate receptor group III pathway": 65,
  "Metal ion SLC transporters": 25,
  "Metal sequestration by antimicrobial proteins": 6,
  "Metalloprotease DUBs": 37,
  "Metallothioneins bind metals": 11,
  "Methionine biosynthesis": 1,
  "Methionine salvage pathway": 6,
  "Methylation": 14,
  "Methylation of MeSeH for excretion": 1,
  "Methylcitrate cycle": 2,
  "Methylmalonyl pathway": 4,
  "MicroRNA (miRNA) biogenesis": 23,
  "Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane": 1,
  "Mineralocorticoid biosynthesis": 6,
  "Minus-strand DNA synthesis": 1,
  "Miscellaneous digestion events": 4,
  "Miscellaneous substrates": 12,
  "Miscellaneous transport and binding events": 19,
  "Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)": 14,
  "Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)": 14,
  "Misspliced GSK3beta mutants stabilize beta-catenin": 15,
  "Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling": 6,
  "Mitochondrial ABC transporters": 4,
  "Mitochondrial Fatty Acid Beta-Oxidation": 22,
  "Mitochondrial Uncoupling Proteins": 5,
  "Mitochondrial biogenesis": 52,
  "Mitochondrial iron-sulfur cluster biogenesis": 7,
  "Mitochondrial protein import": 62,
  "Mitochondrial tRNA aminoacylation": 21,
  "Mitochondrial transcription initiation": 3,
  "Mitochondrial transcription termination": 1,
  "Mitochondrial translation": 92,
  "Mitochondrial translation elongation": 86,
  "Mitochondrial translation initiation": 86,
  "Mitochondrial translation termination": 86,
  "Mitophagy": 22,
  "Mitotic Anaphase": 169,
  "Mitotic G1-G1 S phases": 142,
  "Mitotic G2-G2 M phases": 175,
  "Mitotic Metaphase Anaphase Transition": 2,
  "Mitotic Metaphase and Anaphase": 170,
  "Mitotic Prometaphase": 105,
  "Mitotic Prophase": 132,
  "Mitotic Spindle Checkpoint": 21,
  "Molecules associated with elastic fibres": 30,
  "Molybdenum cofactor biosynthesis": 4,
  "Mtb iron assimilation by chelation": 1,
  "Multifunctional anion exchangers": 9,
  "Muscarinic acetylcholine receptor 1 and 3 signaling pathway": 54,
  "Muscarinic acetylcholine receptor 2 and 4 signaling pathway": 53,
  "Muscarinic acetylcholine receptors": 5,
  "Muscle contraction": 200,
  "MyD88 cascade initiated on plasma membrane": 83,
  "MyD88 deficiency (TLR2 4)": 11,
  "MyD88 deficiency (TLR5)": 3,
  "MyD88 dependent cascade initiated on endosome": 92,
  "MyD88-independent TLR3 TLR4 cascade": 97,
  "MyD88:Mal cascade initiated on plasma membrane": 93,
  "Myoclonic epilepsy of Lafora": 10,
  "Myogenesis": 28,
  "N-Glycan antennae elongation": 15,
  "N-acetylglucosamine degradation I": 3,
  "N-acetylglucosamine degradation II": 4,
  "N-acetylglucosamine metabolism": 6,
  "N-cadherin signaling events": 36,
  "N-glycan antennae elongation in the medial trans-Golgi": 26,
  "N-glycan trimming and elongation in the cis-Golgi": 5,
  "N-glycan trimming in the ER and Calnexin Calreticulin cycle": 35,
  "NAD biosynthesis II (from tryptophan)": 10,
  "NAD biosynthesis III": 4,
  "NAD biosynthesis from 2-amino-3-carboxymuconate semialdehyde": 5,
  "NAD phosphorylation and dephosphorylation": 4,
  "NAD salvage pathway II": 13,
  "NAD salvage pathway III": 5,
  "NADE modulates death signalling": 6,
  "NADH repair": 2,
  "NADPH regeneration": 1,
  "NCAM signaling for neurite out-growth": 258,
  "NCAM1 interactions": 37,
  "NEP NS2 Interacts with the Cellular Export Machinery": 27,
  "NF-kB activation through FADD RIP-1 pathway mediated by caspase-8 and -10": 12,
  "NF-kB is activated and signals survival": 13,
  "NFG and proNGF binds to p75NTR": 2,
  "NGF processing": 4,
  "NGF signalling via TRKA from the plasma membrane": 367,
  "NGF-independant TRKA activation": 5,
  "NICD traffics to nucleus": 13,
  "NIK-->noncanonical NF-kB signaling": 59,
  "NOD1 2 Signaling Pathway": 31,
  "NOSIP mediated eNOS trafficking": 2,
  "NOSTRIN mediated eNOS trafficking": 5,
  "NOTCH1 Intracellular Domain Regulates Transcription": 45,
  "NOTCH2 Activation and Transmission of Signal to the Nucleus": 21,
  "NOTCH2 intracellular domain regulates transcription": 12,
  "NR1D1 (REV-ERBA) represses gene expression": 3,
  "NRAGE signals death through JNK": 59,
  "NRIF signals cell death from the nucleus": 15,
  "NS1 Mediated Effects on Host Pathways": 36,
  "Na+ Cl- dependent neurotransmitter transporters": 19,
  "Na+-dependent glucose transporters": 6,
  "Nectin Necl trans heterodimerization": 7,
  "Nectin adhesion pathway": 30,
  "Nef Mediated CD4 Down-regulation": 9,
  "Nef Mediated CD8 Down-regulation": 7,
  "Nef and signal transduction": 7,
  "Nef mediated downregulation of CD28 cell surface expression": 2,
  "Nef mediated downregulation of MHC class I complex cell surface expression": 10,
  "Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters": 21,
  "Negative epigenetic regulation of rRNA expression": 109,
  "Negative feedback regulation of MAPK pathway": 6,
  "Negative regulation of FGFR1 signaling": 26,
  "Negative regulation of FGFR2 signaling": 28,
  "Negative regulation of FGFR3 signaling": 23,
  "Negative regulation of FGFR4 signaling": 27,
  "Negative regulation of MAPK pathway": 40,
  "Negative regulation of MET activity": 20,
  "Negative regulation of TCF-dependent signaling by DVL-interacting proteins": 4,
  "Negative regulation of TCF-dependent signaling by WNT ligand antagonists": 15,
  "Negative regulation of activity of TFAP2 (AP-2) family transcription factors": 10,
  "Negative regulation of the PI3K AKT network": 80,
  "Negative regulators of RIG-I MDA5 signaling": 34,
  "Nephrin Neph1 signaling in the kidney podocyte": 28,
  "Nephrin interactions": 20,
  "Netrin mediated repulsion signals": 9,
  "Netrin-1 signaling": 41,
  "Netrin-mediated signaling events": 32,
  "Neurodegenerative Diseases": 21,
  "Neurofascin interactions": 7,
  "Neuronal System": 336,
  "Neurophilin interactions with VEGF and VEGFR": 4,
  "Neurotransmitter Clearance In The Synaptic Cleft": 9,
  "Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell": 139,
  "Neurotransmitter Release Cycle": 49,
  "Neurotransmitter uptake and Metabolism In Glial Cells": 4,
  "Neurotrophic factor-mediated Trk receptor signaling": 60,
  "Neutrophil degranulation": 474,
  "Nicotinamide salvaging": 18,
  "Nicotinate metabolism": 29,
  "Nicotine pharmacodynamics pathway": 28,
  "Nicotine_degradation": 9,
  "Nicotinic acetylcholine receptor signaling pathway": 86,
  "Nitric oxide stimulates guanylate cyclase": 23,
  "NoRC negatively regulates rRNA expression": 106,
  "Non-coding RNA Metabolism": 49,
  "Non-integrin membrane-ECM interactions": 42,
  "Noncanonical Wnt signaling pathway": 32,
  "Nongenotropic Androgen signaling": 31,
  "Nonhomologous End-Joining (NHEJ)": 69,
  "Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)": 116,
  "Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)": 96,
  "Nonsense-Mediated Decay (NMD)": 116,
  "Norepinephrine Neurotransmitter Release Cycle": 17,
  "Notch signaling pathway": 29,
  "Notch-HLH transcription pathway": 13,
  "Notch-mediated HES HEY network": 47,
  "NrCAM interactions": 7,
  "Nuclear Envelope Breakdown": 45,
  "Nuclear Envelope Reassembly": 10,
  "Nuclear Events (kinase and transcription factor activation)": 25,
  "Nuclear Pore Complex (NPC) Disassembly": 31,
  "Nuclear Receptor transcription pathway": 39,
  "Nuclear import of Rev protein": 29,
  "Nuclear signaling by ERBB4": 24,
  "Nucleosome assembly": 73,
  "Nucleotide Excision Repair": 110,
  "Nucleotide metabolism": 91,
  "Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways": 50,
  "Nucleotide-like (purinergic) receptors": 16,
  "O-antigen biosynthesis": 3,
  "O-glycosylation of TSR domain-containing proteins": 37,
  "O-linked glycosylation": 108,
  "O-linked glycosylation of mucins": 61,
  "O2 CO2 exchange in erythrocytes": 13,
  "Olfactory Signaling Pathway": 396,
  "Oligomerization of connexins into connexons": 3,
  "Oncogene Induced Senescence": 32,
  "Oncogenic MAPK signaling": 71,
  "Opioid Signalling": 83,
  "Opioid proenkephalin pathway": 30,
  "Opioid proopiomelanocortin pathway": 30,
  "Opsins": 10,
  "Optineurin and Myosin Phosphatase Negatively Regulate PLK1": 3,
  "Orc1 removal from chromatin": 71,
  "Orexin and neuropeptides FF and QRFP bind to their respective receptors": 8,
  "Organelle biogenesis and maintenance": 330,
  "Organic anion transport": 5,
  "Organic anion transporters": 10,
  "Organic cation anion zwitterion transport": 15,
  "Organic cation transport": 10,
  "Ornithine degradation": 3,
  "Osteopontin-mediated events": 31,
  "Other semaphorin interactions": 19,
  "Ovarian tumor domain proteases": 36,
  "Oxidative Stress Induced Senescence": 123,
  "Oxidative demethylation of DNA": 4,
  "Oxidative stress response": 45,
  "Oxygen-dependent asparagine hydroxylation of Hypoxia-inducible Factor Alpha": 3,
  "Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha": 66,
  "Oxytocin receptor mediated signaling pathway": 46,
  "P2Y receptors": 12,
  "P53 pathway feedback loops 1": 5,
  "PAOs oxidise polyamines to amines": 1,
  "PAR1-mediated thrombin signaling events": 43,
  "PAR4-mediated thrombin signaling events": 15,
  "PCNA-Dependent Long Patch Base Excision Repair": 21,
  "PCP CE pathway": 91,
  "PD-1 signaling": 22,
  "PDE3B signalling": 2,
  "PDGF receptor signaling network": 6,
  "PDGF signaling pathway": 124,
  "PDGFR-alpha signaling pathway": 21,
  "PDGFR-beta signaling pathway": 125,
  "PECAM1 interactions": 10,
  "PERK regulates gene expression": 28,
  "PI Metabolism": 76,
  "PI and PC transport between ER and Golgi membranes": 1,
  "PI-3K cascade:FGFR1": 15,
  "PI-3K cascade:FGFR2": 18,
  "PI-3K cascade:FGFR3": 13,
  "PI-3K cascade:FGFR4": 17,
  "PI3 kinase pathway": 43,
  "PI3K AKT Signaling": 110,
  "PI3K AKT Signaling in Cancer": 76,
  "PI3K AKT activation": 113,
  "PI3K Cascade": 71,
  "PI3K events in ERBB2 signaling": 13,
  "PI3K events in ERBB4 signaling": 9,
  "PI5P Regulates TP53 Acetylation": 9,
  "PI5P, PP2A and IER3 Regulate PI3K AKT Signaling": 73,
  "PIWI-interacting RNA (piRNA) biogenesis": 29,
  "PKA activation": 19,
  "PKA activation in glucagon signalling": 17,
  "PKA-mediated phosphorylation of CREB": 20,
  "PKA-mediated phosphorylation of key metabolic factors": 5,
  "PKB-mediated events": 40,
  "PKMTs methylate histone lysines": 71,
  "PLC beta mediated events": 46,
  "PLC-gamma1 signalling": 36,
  "PLC-mediated hydrolysis of PIP2": 4,
  "PLCG1 events in ERBB2 signaling": 4,
  "PLK1 signaling events": 46,
  "PLK2 and PLK4 events": 2,
  "PLK3 signaling events": 5,
  "PNAT": 51,
  "POLB-Dependent Long Patch Base Excision Repair": 7,
  "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation": 12,
  "POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation": 3,
  "PP2A-mediated dephosphorylation of key metabolic factors": 7,
  "PPARA activates gene expression": 116,
  "PRC2 methylates histones and DNA": 73,
  "PRPP biosynthesis": 2,
  "PRPP biosynthesis I": 2,
  "PTK6 Activates STAT3": 4,
  "PTK6 Down-Regulation": 3,
  "PTK6 Expression": 5,
  "PTK6 Regulates Cell Cycle": 6,
  "PTK6 Regulates Proteins Involved in RNA Processing": 5,
  "PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases": 26,
  "PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1": 9,
  "PTK6 promotes HIF1A stabilization": 6,
  "Packaging Of Telomere Ends": 52,
  "Packaging of Eight RNA Segments": 0,
  "Pantothenate biosynthesis": 0,
  "Paradoxical activation of RAF signaling by kinase inactive BRAF": 37,
  "Parkinson disease": 84,
  "Passive transport by Aquaporins": 13,
  "Pausing and recovery of HIV elongation": 36,
  "Pausing and recovery of Tat-mediated HIV elongation": 34,
  "Pentose phosphate pathway": 8,
  "Pentose phosphate pathway (hexose monophosphate shunt)": 9,
  "Peptide chain elongation": 90,
  "Peptide hormone biosynthesis": 11,
  "Peptide hormone metabolism": 85,
  "Peptide ligand-binding receptors": 186,
  "Peptidoglycan biosynthesis": 0,
  "Peroxisomal lipid metabolism": 25,
  "Phase 0 - rapid depolarisation": 46,
  "Phase 1 - Functionalization of compounds": 106,
  "Phase 1 - inactivation of fast Na+ channels": 7,
  "Phase 2 - plateau phase": 27,
  "Phase 3 - rapid repolarisation": 8,
  "Phase 4 - resting membrane potential": 19,
  "Phase II conjugation": 101,
  "Phenylalanine and tyrosine catabolism": 11,
  "Phenylalanine biosynthesis": 0,
  "Phenylethylamine degradation": 3,
  "Phenylpropionate degradation": 0,
  "Phosphate bond hydrolysis by NTPDase proteins": 8,
  "Phosphate bond hydrolysis by NUDT proteins": 4,
  "Phospholipase C-mediated cascade: FGFR1": 11,
  "Phospholipase C-mediated cascade; FGFR2": 14,
  "Phospholipase C-mediated cascade; FGFR3": 9,
  "Phospholipase C-mediated cascade; FGFR4": 13,
  "Phospholipid metabolism": 199,
  "Phosphorylation of CD3 and TCR zeta chains": 21,
  "Phosphorylation of Emi1": 6,
  "Phosphorylation of proteins involved in G1 S transition by active Cyclin E:Cdk2 complexes": 4,
  "Phosphorylation of proteins involved in the G2 M transition by Cyclin A:Cdc2 complexes": 3,
  "Phosphorylation of the APC C": 19,
  "Physiological factors": 12,
  "Pink Parkin Mediated Mitophagy": 22,
  "Plasma membrane estrogen receptor signaling": 40,
  "Plasmalogen biosynthesis": 2,
  "Plasminogen activating cascade": 16,
  "Platelet Adhesion to exposed collagen": 13,
  "Platelet Aggregation (Plug Formation)": 34,
  "Platelet activation, signaling and aggregation": 273,
  "Platelet calcium homeostasis": 30,
  "Platelet degranulation": 127,
  "Platelet homeostasis": 88,
  "Platelet sensitization by LDL": 16,
  "Plus-strand DNA synthesis": 1,
  "Polo-like kinase mediated events": 16,
  "Polo-like kinase signaling events in the cell cycle": 4,
  "Polymerase switching": 14,
  "Polymerase switching on the C-strand of the telomere": 14,
  "Porphyrin metabolism": 17,
  "Positive epigenetic regulation of rRNA expression": 105,
  "Post NMDA receptor activation events": 37,
  "Post-Elongation Processing of Intron-Containing pre-mRNA": 56,
  "Post-Elongation Processing of Intronless pre-mRNA": 28,
  "Post-Elongation Processing of the Transcript": 65,
  "Post-chaperonin tubulin folding pathway": 23,
  "Post-transcriptional silencing by small RNAs": 7,
  "Post-translational modification: synthesis of GPI-anchored proteins": 89,
  "Post-translational protein modification": 1005,
  "Postsynaptic nicotinic acetylcholine receptors": 14,
  "Posttranslational regulation of adherens junction stability and dissassembly": 48,
  "Potassium Channels": 99,
  "Potassium transport channels": 3,
  "Pre-NOTCH Expression and Processing": 45,
  "Pre-NOTCH Processing in Golgi": 18,
  "Pre-NOTCH Processing in the Endoplasmic Reticulum": 6,
  "Pre-NOTCH Transcription and Translation": 29,
  "Prefoldin mediated transfer of substrate to CCT TriC": 28,
  "Pregnenolone biosynthesis": 10,
  "Presenilin action in Notch and Wnt signaling": 46,
  "Presynaptic function of Kainate receptors": 21,
  "Presynaptic nicotinic acetylcholine receptors": 12,
  "Presynaptic phase of homologous DNA pairing and strand exchange": 39,
  "Processing and activation of SUMO": 10,
  "Processing of Capped Intron-Containing Pre-mRNA": 232,
  "Processing of Capped Intronless Pre-mRNA": 28,
  "Processing of DNA double-strand break ends": 98,
  "Processing of Intronless Pre-mRNAs": 19,
  "Processive synthesis on the C-strand of the telomere": 11,
  "Processive synthesis on the lagging strand": 15,
  "Programmed Cell Death": 168,
  "Progressive trimming of alpha-1,2-linked mannose residues from Man9 8 7GlcNAc2 to produce Man5GlcNAc2": 3,
  "Prolactin receptor signaling": 14,
  "Proline biosynthesis": 0,
  "Proline catabolism": 2,
  "Prolonged ERK activation events": 234,
  "Propionyl-CoA catabolism": 5,
  "Prostacyclin signalling through prostacyclin receptor": 19,
  "Prostanoid ligand receptors": 9,
  "Protein folding": 101,
  "Protein methylation": 19,
  "Protein repair": 6,
  "Protein ubiquitination": 62,
  "Protein-protein interactions at synapses": 70,
  "Proteoglycan syndecan-mediated signaling events": 4,
  "Proton oligopeptide cotransporters": 4,
  "Proton-coupled monocarboxylate transport": 6,
  "Proton-coupled neutral amino acid transporters": 2,
  "Purine catabolism": 10,
  "Purine metabolism": 34,
  "Purine ribonucleoside monophosphate biosynthesis": 12,
  "Purine salvage": 13,
  "Pyridoxal phosphate salvage pathway": 2,
  "Pyridoxal-5-phosphate biosynthesis": 2,
  "Pyrimidine Metabolism": 10,
  "Pyrimidine biosynthesis": 5,
  "Pyrimidine catabolism": 11,
  "Pyrimidine metabolism": 23,
  "Pyrimidine salvage reactions": 10,
  "Pyrophosphate hydrolysis": 2,
  "Pyruvate metabolism": 26,
  "Pyruvate metabolism and Citric Acid (TCA) cycle": 47,
  "RA biosynthesis pathway": 22,
  "RAB GEFs exchange GTP for GDP on RABs": 88,
  "RAB geranylgeranylation": 65,
  "RAC1 signaling pathway": 54,
  "RAF MAP kinase cascade": 227,
  "RAF activation": 24,
  "RAF-independent MAPK1 3 activation": 22,
  "RAS signaling downstream of NF1 loss-of-function variants": 4,
  "RET signaling": 251,
  "RHO GTPase Effectors": 284,
  "RHO GTPases Activate Formins": 109,
  "RHO GTPases Activate NADPH Oxidases": 13,
  "RHO GTPases Activate ROCKs": 17,
  "RHO GTPases Activate Rhotekin and Rhophilins": 9,
  "RHO GTPases Activate WASPs and WAVEs": 35,
  "RHO GTPases activate CIT": 16,
  "RHO GTPases activate IQGAPs": 13,
  "RHO GTPases activate KTN1": 11,
  "RHO GTPases activate PAKs": 23,
  "RHO GTPases activate PKNs": 93,
  "RHO GTPases regulate CFTR trafficking": 3,
  "RIG-I MDA5 mediated induction of IFN-alpha beta pathways": 81,
  "RIP-mediated NFkB activation via ZBP1": 21,
  "RIPK1-mediated regulated necrosis": 15,
  "RMTs methylate histone arginines": 79,
  "RNA Pol II CTD phosphorylation and interaction with CE": 27,
  "RNA Pol II CTD phosphorylation and interaction with CE during HIV infection": 27,
  "RNA Polymerase I Chain Elongation": 90,
  "RNA Polymerase I Promoter Clearance": 109,
  "RNA Polymerase I Promoter Escape": 30,
  "RNA Polymerase I Promoter Opening": 63,
  "RNA Polymerase I Transcription": 111,
  "RNA Polymerase I Transcription Initiation": 47,
  "RNA Polymerase I Transcription Termination": 31,
  "RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription": 148,
  "RNA Polymerase II HIV Promoter Escape": 47,
  "RNA Polymerase II Pre-transcription Events": 84,
  "RNA Polymerase II Promoter Escape": 47,
  "RNA Polymerase II Transcription": 149,
  "RNA Polymerase II Transcription Elongation": 61,
  "RNA Polymerase II Transcription Initiation": 47,
  "RNA Polymerase II Transcription Initiation And Promoter Clearance": 47,
  "RNA Polymerase II Transcription Pre-Initiation And Promoter Opening": 47,
  "RNA Polymerase II Transcription Termination": 65,
  "RNA Polymerase III Abortive And Retractive Initiation": 41,
  "RNA Polymerase III Chain Elongation": 18,
  "RNA Polymerase III Transcription": 41,
  "RNA Polymerase III Transcription Initiation": 36,
  "RNA Polymerase III Transcription Initiation From Type 1 Promoter": 28,
  "RNA Polymerase III Transcription Initiation From Type 2 Promoter": 27,
  "RNA Polymerase III Transcription Initiation From Type 3 Promoter": 28,
  "RNA Polymerase III Transcription Termination": 23,
  "RNA polymerase II transcribes snRNA genes": 71,
  "RNF mutants show enhanced WNT signaling and proliferation": 8,
  "RORA activates gene expression": 27,
  "ROS, RNS production in phagocytes": 32,
  "RSK activation": 6,
  "RXR and RAR heterodimerization with other nuclear receptor": 26,
  "Rap1 signalling": 15,
  "Rapid glucocorticoid signaling": 8,
  "Rapoport-Luebering glycolytic shunt": 5,
  "Ras Pathway": 70,
  "Ras activation uopn Ca2+ infux through NMDA receptor": 19,
  "Ras signaling in the CD4+ TCR pathway": 14,
  "Reactions specific to the complex N-glycan synthesis pathway": 10,
  "Reactions specific to the hybrid N-glycan synthesis pathway": 1,
  "Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor": 14,
  "Recognition and association of DNA glycosylase with site containing an affected purine": 3,
  "Recognition and association of DNA glycosylase with site containing an affected pyrimidine": 7,
  "Recognition of DNA damage by PCNA-containing replication complex": 30,
  "Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks": 76,
  "Recruitment of NuMA to mitotic centrosomes": 11,
  "Recruitment of mitotic centrosome proteins and complexes": 76,
  "Recycling of bile acids and salts": 16,
  "Recycling of eIF2:GDP": 8,
  "Recycling pathway of L1": 27,
  "Reduction of cytosolic Ca++ levels": 14,
  "Reelin signaling pathway": 28,
  "Reelin signalling pathway": 5,
  "Regulated Necrosis": 15,
  "Regulated proteolysis of p75NTR": 10,
  "Regulation by TREX1": 1,
  "Regulation by c-FLIP": 10,
  "Regulation of APC C activators between G1 S and early anaphase": 80,
  "Regulation of Androgen receptor activity": 53,
  "Regulation of Apoptosis": 53,
  "Regulation of CDC42 activity": 30,
  "Regulation of Commissural axon pathfinding by Slit and Robo": 3,
  "Regulation of Complement cascade": 27,
  "Regulation of DNA replication": 76,
  "Regulation of FZD by ubiquitination": 21,
  "Regulation of Glucokinase by Glucokinase Regulatory Protein": 27,
  "Regulation of HSF1-mediated heat shock response": 63,
  "Regulation of Hypoxia-inducible Factor (HIF) by oxygen": 75,
  "Regulation of IFNA signaling": 24,
  "Regulation of IFNG signaling": 12,
  "Regulation of IGF Activity by IGFBP": 21,
  "Regulation of KIT signaling": 12,
  "Regulation of PAK-2p34 activity by PS-GAP RHG10": 2,
  "Regulation of PLK1 Activity at G2 M Transition": 84,
  "Regulation of RAC1 activity": 38,
  "Regulation of RAS by GAPs": 68,
  "Regulation of Ras family activation": 33,
  "Regulation of RhoA activity": 46,
  "Regulation of TLR by endogenous ligand": 16,
  "Regulation of TNFR1 signaling": 32,
  "Regulation of TP53 Activity": 160,
  "Regulation of TP53 Activity through Acetylation": 30,
  "Regulation of TP53 Activity through Association with Co-factors": 14,
  "Regulation of TP53 Activity through Methylation": 19,
  "Regulation of TP53 Activity through Phosphorylation": 92,
  "Regulation of TP53 Degradation": 35,
  "Regulation of TP53 Expression": 2,
  "Regulation of TP53 Expression and Degradation": 36,
  "Regulation of Telomerase": 67,
  "Regulation of actin dynamics for phagocytic cup formation": 69,
  "Regulation of activated PAK-2p34 by proteasome mediated degradation": 50,
  "Regulation of beta-cell development": 30,
  "Regulation of cholesterol biosynthesis by SREBP (SREBF)": 53,
  "Regulation of cytoplasmic and nuclear SMAD2 3 signaling": 19,
  "Regulation of cytoskeletal remodeling and cell spreading by IPP complex components": 7,
  "Regulation of gap junction activity": 2,
  "Regulation of gene expression by Hypoxia-inducible Factor": 11,
  "Regulation of gene expression in beta cells": 19,
  "Regulation of gene expression in early pancreatic precursor cells": 7,
  "Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells": 5,
  "Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells": 7,
  "Regulation of innate immune responses to cytosolic DNA": 15,
  "Regulation of insulin secretion": 80,
  "Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)": 118,
  "Regulation of mRNA stability by proteins that bind AU-rich elements": 84,
  "Regulation of mitotic cell cycle": 86,
  "Regulation of necroptotic cell death": 13,
  "Regulation of nuclear SMAD2 3 signaling": 82,
  "Regulation of nuclear beta catenin signaling and target gene transcription": 80,
  "Regulation of ornithine decarboxylase (ODC)": 51,
  "Regulation of p38-alpha and p38-beta": 30,
  "Regulation of pyruvate dehydrogenase (PDH) complex": 14,
  "Regulation of retinoblastoma protein": 65,
  "Regulation of signaling by CBL": 17,
  "Regulation of signaling by NODAL": 11,
  "Regulation of thyroid hormone activity": 3,
  "Relaxin receptors": 8,
  "Release": 0,
  "Release of Hh-Np from the secreting cell": 8,
  "Release of apoptotic factors from the mitochondria": 2,
  "Removal of aminoterminal propeptides from gamma-carboxylated proteins": 10,
  "Removal of licensing factors from origins": 73,
  "Removal of the Flap Intermediate": 14,
  "Removal of the Flap Intermediate from the C-strand": 10,
  "Repression of WNT target genes": 12,
  "Reproduction": 26,
  "Resolution of AP sites via the multiple-nucleotide patch replacement pathway": 24,
  "Resolution of AP sites via the single-nucleotide replacement pathway": 4,
  "Resolution of Abasic Sites (AP sites)": 36,
  "Resolution of D-Loop Structures": 34,
  "Resolution of D-loop Structures through Holliday Junction Intermediates": 33,
  "Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)": 26,
  "Resolution of Sister Chromatid Cohesion": 97,
  "Respiratory electron transport": 100,
  "Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.": 123,
  "Response of Mtb to phagocytosis": 1,
  "Response to elevated platelet cytosolic Ca2+": 132,
  "Response to metal ions": 11,
  "Retinoic acid receptors-mediated signaling": 30,
  "Retinoid cycle disease events": 10,
  "Retinoid metabolism and transport": 43,
  "Retinoid metabolism disease events": 1,
  "Retrograde neurotrophin signalling": 14,
  "Retrograde transport at the Trans-Golgi-Network": 49,
  "Reuptake of GABA": 4,
  "Rev-mediated nuclear export of HIV RNA": 30,
  "Reversal of alkylation damage by DNA dioxygenases": 7,
  "Reverse Transcription of HIV RNA": 1,
  "Reversible hydration of carbon dioxide": 12,
  "Rhesus glycoproteins mediate ammonium transport.": 3,
  "Rho GTPase cycle": 139,
  "RhoA signaling pathway": 45,
  "Ribosomal scanning and start codon recognition": 59,
  "Role of Abl in Robo-Slit signaling": 9,
  "Role of Calcineurin-dependent NFAT signaling in lymphocytes": 53,
  "Role of LAT2 NTAL LAB on calcium mobilization": 124,
  "Role of phospholipids in phagocytosis": 35,
  "Role of second messengers in netrin-1 signaling": 10,
  "S Phase": 128,
  "S-adenosyl-L-methionine biosynthesis": 3,
  "S-adenosylmethionine biosynthesis": 3,
  "S-methyl-5'-thioadenosine degradation II": 1,
  "S-methyl-5-thio-α-D-ribose 1-phosphate degradation": 4,
  "S1P1 pathway": 19,
  "S1P2 pathway": 24,
  "S1P3 pathway": 25,
  "S1P4 pathway": 14,
  "S1P5 pathway": 8,
  "S33 mutants of beta-catenin aren't phosphorylated": 15,
  "S37 mutants of beta-catenin aren't phosphorylated": 15,
  "S45 mutants of beta-catenin aren't phosphorylated": 15,
  "SALM protein interactions at the synapses": 21,
  "SCF(Skp2)-mediated degradation of p27 p21": 60,
  "SCF-beta-TrCP mediated degradation of Emi1": 55,
  "SCW_signaling_pathway": 0,
  "SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion": 14,
  "SHC-mediated cascade:FGFR1": 14,
  "SHC-mediated cascade:FGFR2": 17,
  "SHC-mediated cascade:FGFR3": 12,
  "SHC-mediated cascade:FGFR4": 16,
  "SHC-related events triggered by IGF1R": 7,
  "SHC1 events in EGFR signaling": 227,
  "SHC1 events in ERBB2 signaling": 19,
  "SHC1 events in ERBB4 signaling": 12,
  "SHP2 signaling": 57,
  "SIRT1 negatively regulates rRNA Expression": 68,
  "SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs": 11,
  "SLBP independent Processing of Histone Pre-mRNAs": 10,
  "SLC transporter disorders": 7,
  "SLC-mediated transmembrane transport": 276,
  "SMAC binds to IAPs": 5,
  "SMAC-mediated apoptotic response": 5,
  "SMAC-mediated dissociation of IAP:caspase complexes": 5,
  "SMAD2 3 MH2 Domain Mutants in Cancer": 6,
  "SMAD2 3 Phosphorylation Motif Mutants in Cancer": 5,
  "SMAD2 SMAD3:SMAD4 heterotrimer regulates transcription": 32,
  "SMAD4 MH2 Domain Mutants in Cancer": 3,
  "SOS-mediated signalling": 227,
  "SRP-dependent cotranslational protein targeting to membrane": 113,
  "STAT6-mediated induction of chemokines": 3,
  "STING mediated induction of host immune responses": 16,
  "SUMO E3 ligases SUMOylate target proteins": 93,
  "SUMO is conjugated to E1 (UBA2:SAE1)": 5,
  "SUMO is proteolytically processed": 6,
  "SUMO is transferred from E1 to E2 (UBE2I, UBC9)": 7,
  "SUMOylation": 99,
  "SUMOylation of DNA damage response and repair proteins": 70,
  "SUMOylation of DNA replication proteins": 41,
  "SUMOylation of RNA binding proteins": 41,
  "SUMOylation of chromatin organization proteins": 4,
  "SUMOylation of transcription factors": 16,
  "Salvage pyrimidine deoxyribonucleotides": 3,
  "Salvage pyrimidine ribonucleotides": 10,
  "Scavenging by Class A Receptors": 19,
  "Scavenging by Class B Receptors": 4,
  "Scavenging by Class F Receptors": 6,
  "Scavenging by Class H Receptors": 4,
  "Scavenging of heme from plasma": 22,
  "SeMet incorporation into proteins": 11,
  "Selenoamino acid metabolism": 116,
  "Selenocysteine synthesis": 93,
  "Sema3A PAK dependent Axon repulsion": 16,
  "Sema4D in semaphorin signaling": 27,
  "Sema4D induced cell migration and growth-cone collapse": 24,
  "Sema4D mediated inhibition of cell attachment and migration": 8,
  "Semaphorin interactions": 67,
  "Senescence-Associated Secretory Phenotype (SASP)": 110,
  "Sensing of DNA Double Strand Breaks": 6,
  "Separation of Sister Chromatids": 161,
  "Serine biosynthesis": 8,
  "Serine glycine biosynthesis": 3,
  "Serotonin Neurotransmitter Release Cycle": 16,
  "Serotonin and melatonin biosynthesis": 5,
  "Serotonin receptors": 12,
  "Sialic acid metabolism": 33,
  "Signal amplification": 31,
  "Signal attenuation": 9,
  "Signal regulatory protein (SIRP) family interactions": 11,
  "Signal transduction by L1": 20,
  "Signaling Pathways": 2475,
  "Signaling by Activin": 13,
  "Signaling by Aurora kinases": 3,
  "Signaling by BMP": 23,
  "Signaling by BRAF and RAF fusions": 58,
  "Signaling by EGFR": 344,
  "Signaling by EGFR in Cancer": 18,
  "Signaling by EGFRvIII in Cancer": 14,
  "Signaling by ERBB2": 47,
  "Signaling by ERBB4": 40,
  "Signaling by FGFR": 77,
  "Signaling by FGFR in disease": 58,
  "Signaling by FGFR1": 42,
  "Signaling by FGFR1 in disease": 33,
  "Signaling by FGFR2": 66,
  "Signaling by FGFR2 IIIa TM": 19,
  "Signaling by FGFR2 amplification mutants": 1,
  "Signaling by FGFR2 fusions": 1,
  "Signaling by FGFR2 in disease": 39,
  "Signaling by FGFR3": 33,
  "Signaling by FGFR3 fusions in cancer": 9,
  "Signaling by FGFR3 in disease": 18,
  "Signaling by FGFR3 point mutants in cancer": 18,
  "Signaling by FGFR4": 36,
  "Signaling by FGFR4 in disease": 10,
  "Signaling by GPCR": 1273,
  "Signaling by Hedgehog": 136,
  "Signaling by Hippo": 19,
  "Signaling by Insulin receptor": 303,
  "Signaling by Interleukins": 504,
  "Signaling by Leptin": 233,
  "Signaling by Ligand-Responsive EGFR Variants in Cancer": 18,
  "Signaling by MET": 65,
  "Signaling by MST1": 4,
  "Signaling by NGF": 455,
  "Signaling by NODAL": 20,
  "Signaling by NOTCH": 108,
  "Signaling by NOTCH1": 70,
  "Signaling by NOTCH1 HD Domain Mutants in Cancer": 15,
  "Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer": 56,
  "Signaling by NOTCH1 PEST Domain Mutants in Cancer": 56,
  "Signaling by NOTCH1 in Cancer": 56,
  "Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant": 7,
  "Signaling by NOTCH2": 32,
  "Signaling by NOTCH3": 11,
  "Signaling by NOTCH4": 11,
  "Signaling by Overexpressed Wild-Type EGFR in Cancer": 2,
  "Signaling by PDGF": 355,
  "Signaling by PTK6": 64,
  "Signaling by RAS mutants": 47,
  "Signaling by Retinoic Acid": 42,
  "Signaling by Rho GTPases": 414,
  "Signaling by Robo receptor": 30,
  "Signaling by SCF-KIT": 315,
  "Signaling by TGF-beta Receptor Complex": 72,
  "Signaling by TGF-beta Receptor Complex in Cancer": 7,
  "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)": 281,
  "Signaling by VEGF": 319,
  "Signaling by WNT in cancer": 34,
  "Signaling by Wnt": 327,
  "Signaling by activated point mutants of FGFR1": 8,
  "Signaling by activated point mutants of FGFR3": 9,
  "Signaling by cytosolic FGFR1 fusion mutants": 16,
  "Signaling by high-kinase activity BRAF mutants": 33,
  "Signaling by moderate kinase activity BRAF mutants": 37,
  "Signaling by plasma membrane FGFR1 fusions": 3,
  "Signaling events mediated by HDAC Class I": 66,
  "Signaling events mediated by HDAC Class II": 34,
  "Signaling events mediated by HDAC Class III": 39,
  "Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)": 79,
  "Signaling events mediated by PRL": 23,
  "Signaling events mediated by PTP1B": 52,
  "Signaling events mediated by Stem cell factor receptor (c-Kit)": 51,
  "Signaling events mediated by TCPTP": 39,
  "Signaling events mediated by VEGFR1 and VEGFR2": 68,
  "Signaling events mediated by focal adhesion kinase": 58,
  "Signaling events mediated by the Hedgehog family": 22,
  "Signaling events regulated by Ret tyrosine kinase": 38,
  "Signaling mediated by p38-alpha and p38-beta": 35,
  "Signaling mediated by p38-gamma and p38-delta": 10,
  "Signalling to ERK5": 2,
  "Signalling to ERKs": 245,
  "Signalling to RAS": 238,
  "Signalling to STAT3": 3,
  "Signalling to p38 via RIT and RIN": 231,
  "Small interfering RNA (siRNA) biogenesis": 9,
  "Smooth Muscle Contraction": 35,
  "Sodium Calcium exchangers": 13,
  "Sodium Proton exchangers": 9,
  "Sodium-coupled phosphate cotransporters": 5,
  "Sodium-coupled sulphate, di- and tri-carboxylate transporters": 5,
  "Sperm Motility And Taxes": 9,
  "Sperm:Oocyte Membrane Binding": 5,
  "Sphingolipid de novo biosynthesis": 40,
  "Sphingolipid metabolism": 84,
  "Sphingosine 1-phosphate (S1P) pathway": 21,
  "Spry regulation of FGF signaling": 14,
  "Stabilization and expansion of the E-cadherin adherens junction": 41,
  "Stabilization of p53": 55,
  "Steroid hormones": 39,
  "Sterols are 12-hydroxylated by CYP8B1": 2,
  "Stimulation of the cell death response by PAK-2p34": 2,
  "Stimuli-sensing channels": 102,
  "Striated Muscle Contraction": 34,
  "Succinate to proprionate conversion": 3,
  "Sulfate assimilation": 0,
  "Sulfide oxidation to sulfate": 5,
  "Sulfur amino acid metabolism": 25,
  "Sumoylation by RanBP2 regulates transcriptional repression": 11,
  "Surfactant metabolism": 30,
  "Switching of origins to a post-replicative state": 71,
  "Synaptic_vesicle_trafficking": 21,
  "Syndecan interactions": 20,
  "Syndecan-1-mediated signaling events": 38,
  "Syndecan-2-mediated signaling events": 36,
  "Syndecan-3-mediated signaling events": 21,
  "Syndecan-4-mediated signaling events": 32,
  "Synthesis And Processing Of GAG, GAGPOL Polyproteins": 11,
  "Synthesis and interconversion of nucleotide di- and triphosphates": 25,
  "Synthesis and processing of ENV and VPU": 1,
  "Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)": 9,
  "Synthesis of 12-eicosatetraenoic acid derivatives": 6,
  "Synthesis of 15-eicosatetraenoic acid derivatives": 6,
  "Synthesis of 5-eicosatetraenoic acids": 9,
  "Synthesis of CL": 1,
  "Synthesis of DNA": 100,
  "Synthesis of Dolichyl-phosphate": 6,
  "Synthesis of GDP-mannose": 5,
  "Synthesis of Hepoxilins (HX) and Trioxilins (TrX)": 1,
  "Synthesis of IP2, IP, and Ins in the cytosol": 11,
  "Synthesis of IP3 and IP4 in the cytosol": 28,
  "Synthesis of IPs in the ER lumen": 1,
  "Synthesis of IPs in the nucleus": 4,
  "Synthesis of Ketone Bodies": 8,
  "Synthesis of Leukotrienes (LT) and Eoxins (EX)": 21,
  "Synthesis of Lipoxins (LX)": 6,
  "Synthesis of PA": 33,
  "Synthesis of PC": 28,
  "Synthesis of PE": 13,
  "Synthesis of PG": 8,
  "Synthesis of PI": 5,
  "Synthesis of PIPs at the ER membrane": 2,
  "Synthesis of PIPs at the Golgi membrane": 17,
  "Synthesis of PIPs at the early endosome membrane": 14,
  "Synthesis of PIPs at the late endosome membrane": 10,
  "Synthesis of PIPs at the plasma membrane": 48,
  "Synthesis of PIPs in the nucleus": 4,
  "Synthesis of PS": 2,
  "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)": 15,
  "Synthesis of UDP-N-acetyl-glucosamine": 8,
  "Synthesis of active ubiquitin: roles of E1 and E2 enzymes": 30,
  "Synthesis of bile acids and bile salts": 33,
  "Synthesis of bile acids and bile salts via 24-hydroxycholesterol": 14,
  "Synthesis of bile acids and bile salts via 27-hydroxycholesterol": 15,
  "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol": 23,
  "Synthesis of diphthamide-EEF2": 7,
  "Synthesis of dolichyl-phosphate mannose": 3,
  "Synthesis of dolichyl-phosphate-glucose": 2,
  "Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)": 8,
  "Synthesis of glycosylphosphatidylinositol (GPI)": 15,
  "Synthesis of pyrophosphates in the cytosol": 10,
  "Synthesis of substrates in N-glycan biosythesis": 63,
  "Synthesis of very long-chain fatty acyl-CoAs": 26,
  "Synthesis of wybutosine at G37 of tRNA(Phe)": 6,
  "Synthesis, secretion, and deacylation of Ghrelin": 18,
  "Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)": 19,
  "Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)": 13,
  "T cell activation": 63,
  "T41 mutants of beta-catenin aren't phosphorylated": 15,
  "TAK1 activates NFkB by phosphorylation and activation of IKKs complex": 28,
  "TBC RABGAPs": 44,
  "TCA cycle": 10,
  "TCF dependent signaling in response to WNT": 230,
  "TCF7L2 mutants don't bind CTBP": 3,
  "TCR signaling": 117,
  "TCR signaling in naive CD4+ T cells": 65,
  "TCR signaling in naive CD8+ T cells": 53,
  "TFAP2 (AP-2) family regulates transcription of cell cycle factors": 5,
  "TFAP2 (AP-2) family regulates transcription of growth factors and their receptors": 12,
  "TFAP2 (AP-2) family regulates transcription of other transcription factors": 4,
  "TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation": 5,
  "TGF-beta receptor signaling": 51,
  "TGF-beta receptor signaling activates SMADs": 31,
  "TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)": 16,
  "TGF-beta signaling pathway": 92,
  "TGFBR1 KD Mutants in Cancer": 6,
  "TGFBR1 LBD Mutants in Cancer": 4,
  "TGFBR2 Kinase Domain Mutants in Cancer": 4,
  "TGFBR2 MSI Frameshift Mutants in Cancer": 2,
  "TICAM1 deficiency - HSE": 2,
  "TLR3 deficiency - HSE": 1,
  "TNF receptor signaling pathway": 45,
  "TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway": 16,
  "TNF signaling": 42,
  "TNFR1-induced NFkappaB signaling pathway": 26,
  "TNFR1-induced proapoptotic signaling": 13,
  "TNFR1-mediated ceramide production": 6,
  "TNFR2 non-canonical NF-kB pathway": 100,
  "TNFs bind their physiological receptors": 29,
  "TP53 Regulates Metabolic Genes": 82,
  "TP53 Regulates Transcription of Caspase Activators and Caspases": 12,
  "TP53 Regulates Transcription of Cell Cycle Genes": 48,
  "TP53 Regulates Transcription of Cell Death Genes": 44,
  "TP53 Regulates Transcription of DNA Repair Genes": 65,
  "TP53 Regulates Transcription of Death Receptors and Ligands": 12,
  "TP53 Regulates Transcription of Genes Involved in Cytochrome C Release": 20,
  "TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest": 13,
  "TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest": 18,
  "TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain": 21,
  "TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain": 14,
  "TRAF3 deficiency - HSE": 3,
  "TRAF3-dependent IRF activation pathway": 14,
  "TRAF6 Mediated Induction of proinflammatory cytokines": 81,
  "TRAF6 mediated IRF7 activation": 33,
  "TRAF6 mediated IRF7 activation in TLR7 8 or 9 signaling": 11,
  "TRAF6 mediated NF-kB activation": 24,
  "TRAF6 mediated induction of NFkB and MAP kinases upon TLR7 8 or 9 activation": 90,
  "TRAF6 mediated induction of TAK1 complex": 16,
  "TRAIL signaling": 7,
  "TRAIL signaling pathway": 25,
  "TRIF-mediated TLR3 TLR4 signaling": 97,
  "TRIF-mediated programmed cell death": 10,
  "TRKA activation by NGF": 2,
  "TRP channels": 25,
  "TWIK related potassium channel (TREK)": 3,
  "TWIK-related alkaline pH activated K+ channel (TALK)": 2,
  "TWIK-related spinal cord K+ channel (TRESK)": 1,
  "TWIK-releated acid-sensitive K+ channel (TASK)": 2,
  "Tachykinin receptors bind tachykinins": 5,
  "Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK)": 3,
  "Tandem pore domain halothane-inhibited K+ channel (THIK)": 1,
  "Tandem pore domain potassium channels": 12,
  "Tat-mediated HIV elongation arrest and recovery": 34,
  "Tat-mediated elongation of the HIV-1 transcript": 46,
  "Telomere C-strand (Lagging Strand) Synthesis": 24,
  "Telomere C-strand synthesis initiation": 8,
  "Telomere Extension By Telomerase": 6,
  "Telomere Maintenance": 82,
  "Terminal pathway of complement": 8,
  "Termination of O-glycan biosynthesis": 22,
  "Termination of translesion DNA synthesis": 32,
  "Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation": 12,
  "Tetrahydrofolate biosynthesis": 5,
  "The AIM2 inflammasome": 3,
  "The IPAF inflammasome": 2,
  "The NLRP1 inflammasome": 3,
  "The NLRP3 inflammasome": 12,
  "The activation of arylsulfatases": 13,
  "The canonical retinoid cycle in rods (twilight vision)": 22,
  "The citric acid (TCA) cycle and respiratory electron transport": 166,
  "The fatty acid cycling model": 5,
  "The phototransduction cascade": 33,
  "The proton buffering model": 5,
  "The retinoid cycle in cones (daylight vision)": 7,
  "The role of GTSE1 in G2 M progression after G2 checkpoint": 60,
  "The role of Nef in HIV-1 replication and disease pathogenesis": 27,
  "Thiamin biosynthesis": 0,
  "Thiamine metabolism": 2,
  "Threonine biosynthesis": 1,
  "Threonine catabolism": 1,
  "Thrombin protease-activated receptor (PAR) pathway": 1,
  "Thrombin signalling through proteinase activated receptors (PARs)": 31,
  "Thromboxane A2 receptor signaling": 55,
  "Thromboxane signalling through TP receptor": 23,
  "Thyrotropin-releasing hormone receptor signaling pathway": 56,
  "Thyroxine biosynthesis": 10,
  "Tie2 Signaling": 17,
  "Tight junction interactions": 30,
  "Tolerance by Mtb to nitric oxide produced by macrophages": 0,
  "Tolerance of reactive oxygen produced by macrophages": 0,
  "Toll Like Receptor 10 (TLR10) Cascade": 83,
  "Toll Like Receptor 2 (TLR2) Cascade": 93,
  "Toll Like Receptor 3 (TLR3) Cascade": 97,
  "Toll Like Receptor 4 (TLR4) Cascade": 123,
  "Toll Like Receptor 5 (TLR5) Cascade": 83,
  "Toll Like Receptor 7 8 (TLR7 8) Cascade": 92,
  "Toll Like Receptor 9 (TLR9) Cascade": 96,
  "Toll Like Receptor TLR1:TLR2 Cascade": 93,
  "Toll Like Receptor TLR6:TLR2 Cascade": 93,
  "Toll receptor signaling pathway": 42,
  "Toll-Like Receptors Cascades": 149,
  "Toll_pathway_drosophila": 0,
  "Toxicity of botulinum toxin type A (BoNT A)": 4,
  "Toxicity of botulinum toxin type B (BoNT B)": 3,
  "Toxicity of botulinum toxin type C (BoNT C)": 3,
  "Toxicity of botulinum toxin type D (BoNT D)": 5,
  "Toxicity of botulinum toxin type E (BoNT E)": 3,
  "Toxicity of botulinum toxin type F (BoNT F)": 5,
  "Toxicity of botulinum toxin type G (BoNT G)": 3,
  "Toxicity of tetanus toxin (TeNT)": 1,
  "Trafficking and processing of endosomal TLR": 13,
  "Trafficking of AMPA receptors": 26,
  "Trafficking of GluR2-containing AMPA receptors": 12,
  "Trafficking of dietary sterols": 2,
  "Trafficking of myristoylated proteins to the cilium": 6,
  "Transcription from mitochondrial promoters": 4,
  "Transcription of the HIV genome": 73,
  "Transcription regulation by bZIP transcription factor": 48,
  "Transcription-Coupled Nucleotide Excision Repair (TC-NER)": 78,
  "Transcriptional Regulation by TP53": 360,
  "Transcriptional activation of cell cycle inhibitor p21": 4,
  "Transcriptional activation of mitochondrial biogenesis": 43,
  "Transcriptional activation of p53 responsive genes": 4,
  "Transcriptional activity of SMAD2 SMAD3:SMAD4 heterotrimer": 44,
  "Transcriptional regulation by small RNAs": 102,
  "Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors": 35,
  "Transcriptional regulation of pluripotent stem cells": 34,
  "Transcriptional regulation of white adipocyte differentiation": 83,
  "Transfer of LPS from LBP carrier to CD14": 2,
  "Transferrin endocytosis and recycling": 29,
  "Translation": 157,
  "Translation initiation complex formation": 59,
  "Translesion Synthesis by POLH": 19,
  "Translesion synthesis by POLI": 17,
  "Translesion synthesis by POLK": 17,
  "Translesion synthesis by REV1": 16,
  "Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template": 39,
  "Translocation of GLUT4 to the plasma membrane": 62,
  "Translocation of ZAP-70 to Immunological synapse": 18,
  "Transmembrane transport of small molecules": 661,
  "Transmission across Chemical Synapses": 206,
  "Transmission across Electrical Synapses": 5,
  "Transport and synthesis of PAPS": 6,
  "Transport of HA trimer, NA tetramer and M2 tetramer from the endoplasmic reticulum to the Golgi Apparatus": 0,
  "Transport of Mature Transcript to Cytoplasm": 77,
  "Transport of Mature mRNA Derived from an Intronless Transcript": 36,
  "Transport of Mature mRNA derived from an Intron-Containing Transcript": 68,
  "Transport of Mature mRNAs Derived from Intronless Transcripts": 37,
  "Transport of Ribonucleoproteins into the Host Nucleus": 27,
  "Transport of connexins along the secretory pathway": 3,
  "Transport of connexons to the plasma membrane": 2,
  "Transport of fatty acids": 8,
  "Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus": 9,
  "Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds": 104,
  "Transport of glycerol from adipocytes to the liver by Aquaporins": 2,
  "Transport of inorganic cations anions and amino acids oligopeptides": 105,
  "Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane": 7,
  "Transport of nucleotide sugars": 9,
  "Transport of organic anions": 11,
  "Transport of the SLBP Dependant Mature mRNA": 30,
  "Transport of the SLBP independent Mature mRNA": 29,
  "Transport of vitamins, nucleosides, and related molecules": 38,
  "Transport to the Golgi and subsequent modification": 161,
  "Triacylglycerol metabolism": 2,
  "Triglyceride Biosynthesis": 76,
  "Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA": 16,
  "Trk receptor signaling mediated by PI3K and PLC-gamma": 36,
  "Trk receptor signaling mediated by the MAPK pathway": 34,
  "Truncations of AMER1 destabilize the destruction complex": 14,
  "Tryptophan biosynthesis": 0,
  "Tryptophan catabolism": 13,
  "Type I hemidesmosome assembly": 9,
  "Type II Na+ Pi cotransporters": 3,
  "Tyrosine biosynthesis": 0,
  "U12 Dependent Splicing": 52,
  "UCH proteinases": 102,
  "UDP-D-xylose and UDP-D-glucuronate biosynthesis": 2,
  "UDP-N-acetyl-D-galactosamine biosynthesis I": 1,
  "UDP-N-acetyl-D-galactosamine biosynthesis II": 9,
  "UDP-N-acetyl-D-glucosamine biosynthesis II": 5,
  "UNC93B1 deficiency - HSE": 1,
  "Ub-specific processing proteases": 221,
  "Ubiquinol biosynthesis": 8,
  "Ubiquitin Mediated Degradation of Phosphorylated Cdc25A": 53,
  "Ubiquitin proteasome pathway": 43,
  "Ubiquitin-dependent degradation of Cyclin D": 51,
  "Ubiquitin-dependent degradation of Cyclin D1": 51,
  "Unblocking of NMDA receptor, glutamate binding and activation": 17,
  "Uncoating of the HIV Virion": 1,
  "Uncoating of the Influenza Virion": 0,
  "Unfolded Protein Response (UPR)": 85,
  "Unwinding of DNA": 12,
  "Uptake and actions of bacterial toxins": 27,
  "Uptake and function of anthrax toxins": 9,
  "Uptake and function of diphtheria toxin": 6,
  "Urea cycle": 10,
  "Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling": 42,
  "VEGF and VEGFR signaling network": 10,
  "VEGF binds to VEGFR leading to receptor dimerization": 8,
  "VEGF ligand-receptor interactions": 8,
  "VEGF signaling pathway": 61,
  "VEGFA-VEGFR2 Pathway": 310,
  "VEGFR1 specific signals": 29,
  "VEGFR2 mediated cell proliferation": 239,
  "VEGFR2 mediated vascular permeability": 28,
  "VEGFR3 signaling in lymphatic endothelium": 25,
  "VLDL biosynthesis": 5,
  "VLDL interactions": 23,
  "VLDLR internalisation and degradation": 12,
  "Validated nuclear estrogen receptor alpha network": 64,
  "Validated nuclear estrogen receptor beta network": 15,
  "Validated targets of C-MYC transcriptional activation": 80,
  "Validated targets of C-MYC transcriptional repression": 63,
  "Validated transcriptional targets of AP1 family members Fra1 and Fra2": 37,
  "Validated transcriptional targets of TAp63 isoforms": 54,
  "Validated transcriptional targets of deltaNp63 isoforms": 47,
  "Valine biosynthesis": 3,
  "Vasopressin regulates renal water homeostasis via Aquaporins": 43,
  "Vasopressin synthesis": 11,
  "Vasopressin-like receptors": 6,
  "Vesicle-mediated transport": 646,
  "Vif-mediated degradation of APOBEC3G": 53,
  "Viral Messenger RNA Synthesis": 39,
  "Viral RNP Complexes in the Host Cell Nucleus": 0,
  "Viral mRNA Translation": 90,
  "Virus Assembly and Release": 2,
  "Visual phototransduction": 97,
  "Visual signal transduction: Cones": 23,
  "Visual signal transduction: Rods": 23,
  "Vitamin B1 (thiamin) metabolism": 5,
  "Vitamin B2 (riboflavin) metabolism": 7,
  "Vitamin B5 (pantothenate) metabolism": 17,
  "Vitamin B6 biosynthesis": 0,
  "Vitamin B6 metabolism": 3,
  "Vitamin C (ascorbate) metabolism": 8,
  "Vitamin D (calciferol) metabolism": 7,
  "Vitamin D metabolism and pathway": 8,
  "Vitamins": 6,
  "Vitamins B6 activation to pyridoxal phosphate": 3,
  "Voltage gated Potassium channels": 43,
  "Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization": 3,
  "Vpr-mediated nuclear import of PICs": 29,
  "Vpu mediated degradation of CD4": 52,
  "VxPx cargo-targeting to cilium": 21,
  "WNT ligand biogenesis and trafficking": 26,
  "WNT ligand secretion is abrogated by the PORCN inhibitor LGK974": 1,
  "WNT mediated activation of DVL": 8,
  "WNT5A-dependent internalization of FZD2, FZD5 and ROR2": 13,
  "WNT5A-dependent internalization of FZD4": 15,
  "Wax biosynthesis": 4,
  "Wnt signaling network": 27,
  "Wnt signaling pathway": 264,
  "XAV939 inhibits tankyrase, stabilizing AXIN": 2,
  "XBP1(S) activates chaperone genes": 52,
  "Xanthine and guanine salvage pathway": 4,
  "Xenobiotics": 24,
  "YAP1- and WWTR1 (TAZ)-stimulated gene expression": 29,
  "ZBP1(DAI) mediated induction of type I IFNs": 25,
  "Zinc efflux and compartmentalization by the SLC30 family": 7,
  "Zinc influx into cells by the SLC39 gene family": 10,
  "Zinc transporters": 17,
  "a4b7 Integrin signaling": 8,
  "a6b1 and a6b4 Integrin signaling": 44,
  "acetate conversion to acetyl-CoA": 3,
  "acetyl-CoA biosynthesis III (from citrate)": 1,
  "activated TAK1 mediates p38 MAPK activation": 19,
  "acyl carrier protein metabolism": 1,
  "acyl-CoA hydrolysis": 3,
  "adenine and adenosine salvage I": 1,
  "adenine and adenosine salvage III": 3,
  "adenine and adenosine salvage VI": 1,
  "adenosine nucleotides degradation II": 8,
  "alanine biosynthesis II": 2,
  "alanine biosynthesis III": 1,
  "alanine degradation III": 2,
  "all-trans-decaprenyl diphosphate biosynthesis": 2,
  "alpha-linolenic (omega3) and linoleic (omega6) acid metabolism": 12,
  "alpha-linolenic acid (ALA) metabolism": 12,
  "amb2 Integrin signaling": 31,
  "anandamide degradation": 2,
  "androgen biosynthesis": 7,
  "arginine biosynthesis IV": 6,
  "arginine degradation I (arginase pathway)": 4,
  "arginine degradation VI (arginase 2 pathway)": 5,
  "asparagine biosynthesis I": 1,
  "asparagine degradation I": 2,
  "aspartate biosynthesis": 3,
  "aspartate degradation II": 5,
  "betaKlotho-mediated ligand binding": 3,
  "c-src mediated regulation of Cx43 function and closure of gap junctions": 2,
  "cGMP effects": 17,
  "cRNA Synthesis": 0,
  "calcium transport I": 5,
  "cardiolipin biosynthesis II": 2,
  "catecholamine biosynthesis": 2,
  "cell division": 14,
  "ceramide biosynthesis": 5,
  "ceramide degradation": 1,
  "cholesterol biosynthesis I": 13,
  "cholesterol biosynthesis II (via 24,25-dihydrolanosterol)": 13,
  "cholesterol biosynthesis III (via desmosterol)": 13,
  "choline biosynthesis III": 9,
  "chondroitin sulfate degradation (metazoa)": 6,
  "citrulline degradation": 1,
  "citrulline-nitric oxide cycle": 5,
  "coenzyme A biosynthesis": 3,
  "colanic acid building blocks biosynthesis": 13,
  "creatine-phosphate biosynthesis": 5,
  "cysteine biosynthesis homocysteine degradation": 2,
  "dTMP de novo biosynthesis": 4,
  "dermatan sulfate biosynthesis (late stages)": 4,
  "dermatan sulfate degradation (metazoa)": 4,
  "diphthamide biosynthesis": 1,
  "dolichol and dolichyl phosphate biosynthesis": 3,
  "dolichyl-diphosphooligosaccharide biosynthesis": 9,
  "dopamine degradation": 6,
  "eNOS activation": 12,
  "eNOS activation and regulation": 22,
  "epoxysqualene biosynthesis": 2,
  "ethanol degradation II": 6,
  "ethanol degradation IV": 7,
  "eumelanin biosynthesis": 4,
  "fatty acid activation": 8,
  "fatty acid biosynthesis initiation II": 3,
  "fatty acid α-oxidation II": 10,
  "fatty acid α-oxidation III": 2,
  "fatty acid β-oxidation I": 18,
  "fatty acid β-oxidation III (unsaturated, odd number)": 3,
  "flavin biosynthesis IV (mammalian)": 2,
  "folate polyglutamylation": 5,
  "galactose degradation I (Leloir pathway)": 4,
  "geranylgeranyldiphosphate biosynthesis": 1,
  "gluconeogenesis I": 23,
  "glucose and glucose-1-phosphate degradation": 5,
  "glutamate biosynthesis II": 2,
  "glutamate degradation II": 3,
  "glutamate degradation III (via 4-aminobutyrate)": 4,
  "glutamate degradation X": 2,
  "glutamate dependent acid resistance": 2,
  "glutamate removal from folates": 1,
  "glutamine biosynthesis I": 1,
  "glutamine degradation I": 3,
  "glutaryl-CoA degradation": 5,
  "glutathione biosynthesis": 3,
  "glutathione redox reactions I": 9,
  "glutathione-mediated detoxification I": 23,
  "glycerol degradation I": 3,
  "glycerol-3-phosphate shuttle": 2,
  "glycine biosynthesis I": 2,
  "glycine biosynthesis III": 2,
  "glycine degradation (creatine biosynthesis)": 2,
  "glycogen degradation II": 7,
  "glycogen degradation III": 9,
  "glycolysis I": 23,
  "guanine and guanosine salvage I": 2,
  "guanosine nucleotides degradation III": 4,
  "heme biosynthesis II": 9,
  "heme biosynthesis from uroporphyrinogen-III I": 4,
  "histamine biosynthesis": 1,
  "histamine degradation": 3,
  "histidine degradation III": 7,
  "inosine-5'-phosphate biosynthesis II": 3,
  "inositol pyrophosphates biosynthesis": 7,
  "ketogenesis": 6,
  "ketolysis": 6,
  "lactose degradation III": 1,
  "lanosterol biosynthesis": 1,
  "leukotriene biosynthesis": 6,
  "lysine degradation II": 3,
  "mRNA 3'-end processing": 56,
  "mRNA Capping": 29,
  "mRNA Editing": 10,
  "mRNA Editing: A to I Conversion": 2,
  "mRNA Editing: C to U Conversion": 8,
  "mRNA Splicing": 184,
  "mRNA decay by 3' to 5' exoribonuclease": 16,
  "mRNA decay by 5' to 3' exoribonuclease": 15,
  "mRNA splicing": 6,
  "mTOR signaling pathway": 66,
  "mTOR signalling": 39,
  "mTORC1-mediated signalling": 22,
  "methylglyoxal degradation I": 3,
  "methylglyoxal degradation III": 3,
  "methylglyoxal degradation VI": 1,
  "methylmalonyl pathway": 3,
  "methylthiopropionate biosynthesis": 1,
  "mevalonate pathway I": 12,
  "mitochondrial L-carnitine shuttle pathway": 3,
  "mitochondrial fatty acid beta-oxidation of saturated fatty acids": 10,
  "mitochondrial fatty acid beta-oxidation of unsaturated fatty acids": 6,
  "molybdenum cofactor biosynthesis": 4,
  "myo-inositol biosynthesis": 4,
  "noradrenaline and adrenaline degradation": 10,
  "oleate biosynthesis II (animals)": 7,
  "oxidative ethanol degradation III": 6,
  "oxidized GTP and dGTP detoxification": 1,
  "p130Cas linkage to MAPK signaling for integrins": 14,
  "p38 MAPK pathway": 32,
  "p38 MAPK signaling pathway": 29,
  "p38 signaling mediated by MAPKAP kinases": 21,
  "p38MAPK events": 12,
  "p53 pathway": 45,
  "p53 pathway by glucose deprivation": 21,
  "p53 pathway feedback loops 2": 43,
  "p53-Dependent G1 DNA Damage Response": 64,
  "p53-Dependent G1 S DNA damage checkpoint": 64,
  "p53-Independent DNA Damage Response": 53,
  "p53-Independent G1 S DNA damage checkpoint": 53,
  "p63 transcription factor network": 1,
  "p73 transcription factor network": 78,
  "p75 NTR receptor-mediated signalling": 95,
  "p75(NTR)-mediated signaling": 68,
  "p75NTR negatively regulates cell cycle via SC1": 6,
  "p75NTR recruits signalling complexes": 13,
  "p75NTR regulates axonogenesis": 9,
  "p75NTR signals via NF-kB": 16,
  "pentose phosphate pathway": 10,
  "pentose phosphate pathway (non-oxidative branch)": 6,
  "pentose phosphate pathway (oxidative branch)": 4,
  "phenylalanine degradation I (aerobic)": 4,
  "phenylethylamine degradation I": 4,
  "phosphatidylcholine biosynthesis I": 6,
  "phosphatidylethanolamine biosynthesis II": 6,
  "phosphatidylethanolamine biosynthesis III": 1,
  "phosphatidylglycerol biosynthesis II (non-plastidic)": 18,
  "phospho-PLA2 pathway": 2,
  "phospholipases": 36,
  "phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex": 15,
  "pre-mRNA splicing": 176,
  "proline biosynthesis I": 3,
  "proline biosynthesis II (from arginine)": 4,
  "protein citrullination": 5,
  "purine nucleotides de novo biosynthesis II": 11,
  "purine nucleotides degradation II (aerobic)": 12,
  "purine ribonucleosides degradation to ribose-1-phosphate": 2,
  "putrescine biosynthesis III": 2,
  "putrescine degradation III": 10,
  "pyridoxal 5'-phosphate salvage pathway": 2,
  "pyrimidine ribonucleotides de novo biosynthesis": 14,
  "pyrimidine ribonucleotides interconversion": 12,
  "pyruvate fermentation to lactate": 5,
  "rRNA modification in the mitochondrion": 6,
  "rRNA modification in the nucleus and cytosol": 59,
  "rRNA processing": 193,
  "rRNA processing in the mitochondrion": 10,
  "rRNA processing in the nucleus and cytosol": 183,
  "salvage pathways of pyrimidine deoxyribonucleotides": 5,
  "salvage pathways of pyrimidine ribonucleotides": 15,
  "selenocysteine biosynthesis II (archaea and eukaryotes)": 5,
  "serine biosynthesis": 3,
  "serotonin and melatonin biosynthesis": 5,
  "serotonin degradation": 9,
  "snRNP Assembly": 49,
  "sorbitol degradation I": 1,
  "spermidine biosynthesis I": 2,
  "spermine and spermidine degradation I": 5,
  "spermine biosynthesis": 2,
  "sphingomyelin metabolism": 7,
  "sphingosine and sphingosine-1-phosphate metabolism": 9,
  "stearate biosynthesis I (animals)": 12,
  "sucrose degradation V (mammalian)": 6,
  "sulfate activation for sulfonation": 2,
  "sulfite oxidation IV": 1,
  "superoxide radicals degradation": 5,
  "superpathway of D-myo-inositol (1,4,5)-trisphosphate metabolism": 20,
  "superpathway of cholesterol biosynthesis": 27,
  "superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate)": 14,
  "superpathway of inositol phosphate compounds": 66,
  "superpathway of serine and glycine biosynthesis I": 5,
  "t(4;14) translocations of FGFR3": 1,
  "tRNA Aminoacylation": 42,
  "tRNA charging": 37,
  "tRNA modification in the mitochondrion": 7,
  "tRNA modification in the nucleus and cytosol": 40,
  "tRNA processing": 100,
  "tRNA processing in the mitochondrion": 5,
  "tRNA processing in the nucleus": 53,
  "tRNA splicing": 5,
  "taurine biosynthesis": 2,
  "tetrahydrobiopterin biosynthesis I": 3,
  "tetrahydrobiopterin biosynthesis II": 3,
  "tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate": 4,
  "tetrapyrrole biosynthesis II": 5,
  "thiamin salvage III": 1,
  "thio-molybdenum cofactor biosynthesis": 1,
  "thiosulfate disproportionation III (rhodanese)": 1,
  "threonine degradation II": 1,
  "thymine degradation": 8,
  "thyroid hormone biosynthesis": 2,
  "trans, trans-farnesyl diphosphate biosynthesis": 4,
  "trans-Golgi Network Vesicle Budding": 72,
  "trehalose degradation II (trehalase)": 4,
  "triacylglycerol biosynthesis": 22,
  "triacylglycerol degradation": 12,
  "truncated APC mutants destabilize the destruction complex": 14,
  "tryptophan degradation III (eukaryotic)": 11,
  "tryptophan degradation X (mammalian, via tryptamine)": 5,
  "tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde": 5,
  "tyrosine biosynthesis IV": 1,
  "tyrosine degradation I": 5,
  "urate biosynthesis inosine 5'-phosphate degradation": 8,
  "urea cycle": 6,
  "uridine-5'-phosphate biosynthesis": 2,
  "vRNA Synthesis": 0,
  "vRNP Assembly": 2,
  "xanthine and xanthosine salvage": 1,
  "zymosterol biosynthesis": 6,
  "α-tocopherol degradation": 1,
  "β-alanine degradation I": 2,
  "γ-glutamyl cycle": 12
}